e6vk
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
July 27, 2007
QIMONDA AG
Gustav-Heinemann-Ring 212
D-81739 Munich
Federal Republic of Germany
Tel: +49-89-60088-0
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form
20-F or Form 40-F.
Indicate by check mark whether the registrant by furnishing the information contained in this Form
is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
If Yes is marked, indicate below the file number assigned to the registrant in connection with
Rule 12g3-2(b): 82-___.
This
Report on Form 6-K contains the quarterly report for the third financial quarter ended
June 30, 2007 of Qimonda AG dated July 27, 2007.
QIMONDA AG AND
SUBSIDIARIES
QUARTERLY REPORT
FOR THE THREE AND NINE MONTHS
ENDED
JUNE 30, 2007
INDEX
|
|
|
|
|
Page
|
|
|
|
1
|
|
|
10
|
|
|
11
|
|
|
12
|
|
|
13
|
|
|
14
|
|
|
15
|
|
|
37
|
|
|
39
|
i
(This page is intentionally left blank)
OVERVIEW OF
FINANCIAL RESULTS
Three And Nine
Months Ended June 30, 2007 Compared To Three And Nine
Months Ended June 30, 2006
Net
Sales
The following table presents data on our net sales for the
periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended June
30,
|
|
ended June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except percentages)
|
|
|
percentages)
|
|
|
|
Net sales
|
|
|
977
|
|
|
740
|
|
|
|
2,583
|
|
|
2,897
|
|
Effect of foreign exchange over
prior period
|
|
|
|
|
|
(55
|
)
|
|
|
|
|
|
(238
|
)
|
% of net sales
|
|
|
|
|
|
(7%
|
)
|
|
|
|
|
|
(8%
|
)
|
Our net sales in the nine months ended June 30, 2007
increased by 314 million, or 12%, from
2,583 million in the nine months ended June 30,
2006 to 2,897 million in the nine months ended
June 30, 2007. Primarily responsible for this increase were:
|
|
|
|
|
substantially higher bit shipments.
|
Offsetting these increases in part were
|
|
|
|
|
decreases in our average selling prices for DRAM products, and
|
|
|
|
decreases related to exchange rate effects.
|
Increase in bit shipments. Our bit shipments
increased by 49% during the nine months ended June 30, 2007
compared to the nine months ended June 30, 2006 due to
increasing manufacturing output and improved demand in all
geographical regions. Demand for our products was especially
high in the PC market, as PC makers increased the amount of DRAM
per system (or bits per box), and we believe we
gained market share in non-PC applications, in particular in the
markets for DRAM products for infrastructure, graphics and
mobile applications. During the nine months ended June 30,
2007, close to 63% of our capacities were converted to the 90nm
and below technology nodes, compared to approximately 17% for
the nine months ended June 30, 2006. With the ramp-down of
our flash business, we have shifted additional capacities to
DRAM.
Price decreases. The nine month period ended
June 30, 2007 was characterized by strong price declines
for DRAM products. After remaining stable until the end of
December 2006, prices declined significantly thereafter. We
believe that a part of this price decline, especially towards
the end of March 2007, was driven by seasonal demand weakness,
the effects of an earlier build-up of inventories at original
equipment manufacturers (OEMs) ahead of the introduction of the
new Windows Vista computer operating system and capacity
conversions from NAND to DRAM by some competitors, following
severe price erosion in the NAND Flash area. During the three
months ended June 30, 2007 the price decline continued and
was amplified by strong DRAM output growth across the industry
driven, we believe, mostly by capacity increases and technology
conversions to more efficient technologies.
During the nine months ended June 30, 2006, by contrast,
average selling prices (for DDR2 memories in particular) first
declined very substantially until the end of December 2005, due,
we believe, to a mismatch caused by high worldwide production of
DDR2 memories for which OEMs had not yet produced enough logic
chipsets. DDR2 prices then started to rebound in the following
six months to June 30, 2006 as the corresponding chipsets
became more available.
Overall the average selling prices of our DRAM products were 17%
lower in the nine months ended June 30, 2007 as compared to
the nine months ended June 30, 2006, while our average
selling prices declined by 48% during the three months ended
June 30, 2007 compared to the three months ended
June 30, 2006.
We continue to expect that prices for standard DRAM products
will decline over time in line with the long-term trend across
the industry as a whole. Such declines can sometimes be severe,
as we experienced in the last six months. We intend to mitigate
the impact of declining prices by reducing our costs per unit
and continuing to diversify our product mix.
1
In the three months ended June 30, 2007, our share of bit
shipments to non-PC applications was 49% due to seasonality in
the consumer and infrastructure markets and stronger than
expected bit growth in the PC market. However for the nine
months ended June 30, 2007, our share of bit-shipments to
non-PC applications was 52%.
Exchange rate effects. The U.S. dollar
weakened against the euro in the first nine months of financial
year 2007, with the average exchange rate for the period 8%
lower than it was for the corresponding period of our 2006
financial year. This unfavorable U.S. dollar to euro
exchange rate negatively affected our revenues during the nine
months ended June 30, 2007. We have calculated the effects
of this translation risk as follows: we would have achieved
238 million more in net sales in the nine months
ended June 30, 2007, had the average exchange rates we used
to translate our non-euro denominated sales into euros been the
same in the nine months ended June 30, 2007 as they were in
the nine months ended June 30, 2006.
Net
Sales by Region
The following table sets forth our sales by region for the
periods indicated.
Net sales by region
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months ended June 30,
|
|
For the nine
months ended June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except percentages)
|
|
(in millions,
except percentages)
|
|
Germany
|
|
|
74
|
|
|
|
8%
|
|
|
|
52
|
|
|
|
7%
|
|
|
|
223
|
|
|
|
9%
|
|
|
|
212
|
|
|
|
7%
|
|
Rest of Europe
|
|
|
142
|
|
|
|
14%
|
|
|
|
65
|
|
|
|
9%
|
|
|
|
331
|
|
|
|
13%
|
|
|
|
331
|
|
|
|
11%
|
|
North America
|
|
|
406
|
|
|
|
42%
|
|
|
|
244
|
|
|
|
33%
|
|
|
|
1,078
|
|
|
|
42%
|
|
|
|
1,093
|
|
|
|
38%
|
|
Asia/Pacific
|
|
|
312
|
|
|
|
32%
|
|
|
|
229
|
|
|
|
31%
|
|
|
|
837
|
|
|
|
32%
|
|
|
|
898
|
|
|
|
31%
|
|
Japan
|
|
|
43
|
|
|
|
4%
|
|
|
|
150
|
|
|
|
20%
|
|
|
|
114
|
|
|
|
4%
|
|
|
|
363
|
|
|
|
13%
|
|
Total
|
|
|
977
|
|
|
|
100%
|
|
|
|
740
|
|
|
|
100%
|
|
|
|
2,583
|
|
|
|
100%
|
|
|
|
2,897
|
|
|
|
100%
|
|
The increased sales in Japan during the nine months ended
June 30, 2007, resulted from a strong growth in demand for
our specialty products, in particular for graphics and consumer
applications as well as additional demand for standard DRAM,
during the nine months ended June 30, 2007. The decrease in
sales in North America for the three months ended June 30,
2007, as compared to the previous period, was primarily caused
by OEM customers shifting their production to Asia. For
practical purposes, the Rest of Europe region also includes
other countries and territories in the rest of the world outside
of the listed main geographic regions with aggregate sales
representing no more than 2% of total sales in any period.
Cost
of Goods Sold and Gross Margin
The following table sets forth our cost of goods sold and
related data for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended June
30,
|
|
ended June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except percentages)
|
|
|
percentages)
|
|
|
|
Cost of goods sold
|
|
|
(762
|
)
|
|
|
(964
|
)
|
|
|
(2,158
|
)
|
|
|
(2,572
|
)
|
% of net sales
|
|
|
78%
|
|
|
|
130%
|
|
|
|
84%
|
|
|
|
89%
|
|
Gross margin (loss)
|
|
|
22%
|
|
|
|
(30%
|
)
|
|
|
16%
|
|
|
|
11%
|
|
Cost of goods sold increased by 414 million, or 19%,
from 2,158 million in the nine months ended
June 30, 2006 to 2,572 million in the nine
months ended June 30, 2007. As a percentage of net sales,
cost of goods sold increased from 84% to 89% over the same
period. The absolute increase in our cost of goods sold was due
primarily to:
|
|
|
|
|
substantially higher bit shipments;
|
|
|
|
increased purchases from foundries; and
|
|
|
|
effects from inventory revaluation and reserves.
|
2
Offsetting these increases in part were:
|
|
|
|
|
improvements in our productivity; and
|
|
|
|
exchange rate effects.
|
Higher bit shipments. The 49% increase in bit
shipments in the nine months ended June 30, 2007 compared
to the nine months ended June 30, 2006 was due primarily to
the substantial increase in demand described above, which we met
through further ramp-up of production volumes at our Richmond
300mm facility and higher purchases from foundries and joint
ventures.
Increased purchases from foundries. We report
as cost of goods sold the cost of inventory purchased from our
joint ventures and other associated and related companies such
as Inotera. Our purchases from these affiliated entities
amounted to 403 million in the nine months ended
June 30, 2007 as compared to 330 million in the
nine months ended June 30, 2006. In addition, we purchased
571 million of inventory from our foundry partners
Winbond, SMIC and Infineon in the nine months ended
June 30, 2007 compared to 557 million in the
nine months ended June 30, 2006. In the nine months ended
June 30, 2007, we sourced 58% of our chips from these
partners as compared to 57% during the nine months ended
June 30, 2006.
Inventory revaluation and reserves. We value
our inventory on a quarterly basis at the lower of cost or
market value. If the market price declines below the full
production cost of a particular product, then all inventories of
that product are written down to its market price. For some of
our products, the significant price decline in the three months
ended June 30, 2007 resulted in the write-down of inventory
to market value in an amount of 66 million in
accordance with our policy. Due to the volatility of the DRAM
market, write-downs of this nature may occur in periods of sharp
price decline.
Improved productivity. Similar to our 2006
financial year, we achieved productivity improvements through
the increased conversion of capacities to 90nm, 80nm and 75nm
process technologies and the increasing share of our chips
produced on 300mm wafers. The ramp-up of 300mm capacities at our
Richmond facility, our joint venture Inotera and our foundry
partners SMIC and Winbond contributed to the increased share of
production on 300mm wafers. Measured in wafer starts, 73% of our
total production (including capacity sourced from our strategic
and foundry partners) was on 300mm wafers in the nine months
ended June 30, 2007 as compared to 67% of our production in
the nine months ended June 30, 2006. We believe that
productivity improvements, together with a larger sales volume
over which our fixed costs are spread, permitted us to achieve a
percentage increase in costs that was below the percentage
increase in bit shipments.
Exchange rate effects. The relative decrease
of the exchange rate of the U.S. dollar against the euro in
the nine months ended June 30, 2007, as compared to the
equivalent period one year earlier, decreased the euro value of
our costs that are denominated in U.S. dollars by
approximately 139 million. This means that we would
have incurred approximately 139 million more in costs
of goods sold in our nine months ended June 30, 2007, had
the average exchange rates we used to translate our non-euro
expenses into euros been the same in the nine months ended
June 30, 2007 as they were in the nine months ended
June 30, 2006. However, considered together with the
decrease in our net sales due to negative foreign exchange
effects of 99 million, net, foreign currency
movements overall had a negative net effect on our gross margin
during the nine months ended June 30, 2007.
Our gross margin decreased to 11% during the nine months ended
June 30, 2007, from 16% in the nine months ended
June 30, 2006, primarily due to lower average selling
prices and inventory write downs due to lower selling prices
which could not be compensated by lower production cost per unit
resulting from increased manufacturing productivity and lower
transfer prices from foundry partners.
While average selling prices, especially for standard DRAM
products, generally decline over time, they can display
significant volatility from period to period. Our gross margin
suffers in periods in which prices decline faster than we can
reduce our unit costs and is stronger during periods when prices
decrease more slowly or increase. Due to the significant decline
in average selling prices in the three months ended June 2007,
our gross margin decreased from 20% for the three months ended
March 31, 2007 to a negative margin of 30% for the three
months ended June 30, 2007.
3
Research
and Development (R&D) Expenses
The following table sets forth our R&D expenses for the
periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except
|
|
|
percentages)
|
|
percentages)
|
|
Research and development expenses
|
|
|
(110
|
)
|
|
|
(98
|
)
|
|
|
(325
|
)
|
|
|
(291
|
)
|
% of net sales
|
|
|
11%
|
|
|
|
13%
|
|
|
|
13%
|
|
|
|
10%
|
|
In the nine months ended June 30, 2007, research and
development expenses decreased by 10% to 291 million,
from 325 million in the nine months ended
June 30, 2006, due to the completion of R&D work on
our 80nm and 75nm technology platforms. However, we do expect
our R&D expenses to increase in the current and future
quarters as we continue to invest in product design for our
broadening product portfolio and in advanced technologies that
support new and next generation of our products.
Selling,
General and Administrative (SG&A) Expenses
The following table sets forth information on our selling,
general and administrative expenses for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except
|
|
|
percentages)
|
|
percentages)
|
|
Selling, general and
administrative expenses
|
|
|
(48
|
)
|
|
|
(48
|
)
|
|
|
(161
|
)
|
|
|
(140
|
)
|
% of net sales
|
|
|
5%
|
|
|
|
6%
|
|
|
|
6%
|
|
|
|
5%
|
|
During the nine months ended June 30, 2007, selling,
general and administrative expenses decreased by 13% as compared
to the same period in the prior year. The primary reason for the
decline was that during the nine months ended June 30, 2007
the combined costs under our post carve-out service agreements
with Infineon and to build out our corporate functions were less
than these costs and the costs Infineon allocated to us until
our carve-out for the nine months ended June 30, 2006. We
also incurred lower costs in the nine months ended June 30,
2007 than we did for the same period one year earlier for
special projects, such as our carve-out and IPO.
Other
Operating (Expense) Income, Net
The following table sets forth information on our other
operating (expense) income, net for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except
|
|
|
percentages)
|
|
percentages)
|
|
Other operating income (expense),
net
|
|
|
1
|
|
|
4
|
|
|
(13
|
)
|
|
|
7
|
% of net sales
|
|
|
0%
|
|
|
1%
|
|
|
1%
|
|
|
|
0%
|
Other operating (expense) income, net contains various items
related to our operations, and may fluctuate from period to
period due to the more or less infrequent nature of these items,
which include subsidies, grants, insurance proceeds and accruals
for legal matters. Other operating expenses, net for the nine
months ended June 30, 2006 related principally to charges
from our settlement of an antitrust investigation by the
U.S. Department of Justice and related actions as well as a
related ongoing investigation in Europe. Other operating income,
net in the nine months ended June 30, 2007 related
primarily to subsidies and proceeds from insurance claims.
4
Equity
in Earnings of Associated Companies
The following table sets forth information on our equity in
earnings of associated companies for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except
|
|
|
percentages)
|
|
percentages)
|
|
Equity in earnings of associated
companies
|
|
|
11
|
|
|
38
|
|
|
38
|
|
|
103
|
% of net sales
|
|
|
1%
|
|
|
5%
|
|
|
1%
|
|
|
4%
|
The equity in earnings of associated companies with financial
year ends that differ by not more than three months from the
Companys financial year are recorded on a three month lag.
This applies in particular to our joint venture Inotera
Memories, which has a December 31 financial year end. In
both periods, Inotera contributed most of our equity in earnings
from associated companies, which increased in the three and nine
months ended June 30, 2007, primarily due to the increased
volume production by Inotera and the on average higher selling
prices during the respective three and nine month Inotera
periods ended March 31, 2007 compared to Inoteras
three and nine months periods ended March 31, 2006. Our
equity in this ventures earnings has been sensitive to
fluctuations in the price of DRAM and we reflect changes in our
equity in Inoteras earnings by adjusting the portion of
carrying value of our unsold inventory that we purchased from
Inotera that represents our inter-company profit.
Gain
on associated company share issuance
The following table sets forth information on our gain on
associated company share issuance for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except
|
|
|
percentages)
|
|
percentages)
|
|
Gain on associated company share
issuance
|
|
|
30
|
|
|
0
|
|
|
30
|
|
|
0
|
% of net sales
|
|
|
3%
|
|
|
0%
|
|
|
1%
|
|
|
0%
|
On March 17, 2006 Inotera successfully completed an initial
public offering (IPO) on the Taiwanese stock
exchange of 200 million ordinary shares, representing 7.97%
of its outstanding share capital before IPO, for an issuance
price of NT$33 per ordinary share. As a result, the
Companys ownership interest was diluted from 45.9% to
41.4% while its proportional share of Inoteras equity
increased by approximately 30 million, which gain the
Company recognized as part of non-operating income during the
nine months ended June 30, 2006.
Other
Non-Operating Income, Net
The following table sets forth information on other
non-operating income for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except
|
|
|
percentages)
|
|
percentages)
|
|
Other non-operating income, net
|
|
|
3
|
|
|
6
|
|
|
9
|
|
|
12
|
% of net sales
|
|
|
0%
|
|
|
1%
|
|
|
0%
|
|
|
0%
|
Other non-operating income, net consists of various items from
period to period not directly related to our principal
operations, including gains and losses on sales of marketable
securities. In the nine months ended June 30, 2007, other
non-operating income related principally to the valuation of
derivatives, dividend income and a gain of 2 million
on the sale of our investment in Ramtron, whereas in the nine
months ended June 30, 2006, other non-operating income
related principally to foreign currency transaction gains.
5
Earnings
(Loss) Before Interest and Taxes
(EBIT)
EBIT is a non-GAAP financial measure which is determined from
our combined and consolidated statements of operations as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except
|
|
|
percentages)
|
|
percentages)
|
|
Net income (loss)
|
|
|
54
|
|
|
(218
|
)
|
|
|
(82
|
)
|
|
|
16
|
|
Add: interest expense (income)
|
|
|
6
|
|
|
(1
|
)
|
|
|
22
|
|
|
|
(4
|
)
|
Add: income tax expense (benefit)
|
|
|
40
|
|
|
(104
|
)
|
|
|
58
|
|
|
|
|
|
EBIT
|
|
|
100
|
|
|
(323
|
)
|
|
|
(2
|
)
|
|
|
12
|
|
Interest
(Expense) Income, Net
The following table sets forth information on our net interest
(expense) income, net for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except percentages)
|
|
|
percentages)
|
|
|
|
Interest (expense) income, net
|
|
|
(6
|
)
|
|
|
1
|
|
|
(22
|
)
|
|
|
4
|
% of net sales
|
|
|
(1%
|
)
|
|
|
0%
|
|
|
(1%
|
)
|
|
|
0%
|
Interest expense mainly relates to interest on short-term debt
due to Infineon, while we earn interest income on cash and cash
equivalents and marketable securities. Our interest expense
decreased during the three and nine months periods ended
June 30, 2007, due to our lower average borrowings from
Infineon, as we repaid 48 million of outstanding debt
to Infineon during the three months ended June 30, 2007 and
a total of 344 million of outstanding debt to
Infineon during the nine months ended June 30, 2007. We no
longer have any outstanding debt to Infineon.
Income
Taxes
The following table sets forth information on our income taxes
for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in millions,
except
|
|
(in millions,
except percentages)
|
|
|
percentages)
|
|
|
|
Income tax (expense) benefit
|
|
|
(40
|
)
|
|
|
104
|
|
|
|
(58
|
)
|
|
|
0
|
% of net sales
|
|
|
4%
|
|
|
|
(14%
|
)
|
|
|
2%
|
|
|
|
0%
|
Effective tax rate
|
|
|
43%
|
|
|
|
32%
|
|
|
|
(242%
|
)
|
|
|
0%
|
In the three and nine months ended June 30, 2007, our
effective tax rate was lower than the combined German statutory
tax rate of 39%. This resulted from income in jurisdictions with
lower than average corporate tax rates, tax credits, and
valuation allowances. In the three and nine months ended
June 30, 2006, the effective tax rate did not fully reflect
the income and loss, respectively, for the period due to
deferred tax benefits that could not be recognized, because for
certain jurisdictions losses prior to our carve out could not be
used to offset taxable income after the carve-out.
In July 2007 the German legislature passed the Corporate Tax
Reform Act 2008. This bill introduces several changes to the
taxation of German business activities, including a reduction of
the combined corporate and trade tax rate in Germany from
approximately 39% to 30%. If the bill is enacted into law, most
of the changes would come into effect for our 2008 financial
year. Upon enactment, which could be during the three months
ending September 30, 2007, we would record the reduction in
value of our deferred tax assets in Germany at that date as tax
expense.
In China, as a result of enacted tax reform legislation, a new
uniform income tax regime will become effective from
January 1, 2008. We incorporated these changes in our
effective and deferred tax rate which did not have a material
impact for the three and nine months ended June 30, 2007.
6
Net
Income (Loss)
Our net result increased from a net loss of
82 million in the nine months ended June 30,
2006 to net income of 16 million in the nine months
ended June 30, 2007.
Financial
Condition
The following table sets forth selected items from our
consolidated balance sheets for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
As of
|
|
|
|
|
September 30
|
|
June 30
|
|
|
|
|
2006
|
|
2007
|
|
Change(1)
|
|
|
(in millions,
except
|
|
|
|
|
percentages)
|
|
|
|
Current assets
|
|
|
2,807
|
|
|
2,185
|
|
|
(22%
|
)
|
Non-Current assets
|
|
|
3,054
|
|
|
3,179
|
|
|
4%
|
|
Total assets
|
|
|
5,861
|
|
|
5,364
|
|
|
(8%
|
)
|
Current liabilities
|
|
|
1,479
|
|
|
1,106
|
|
|
(25%
|
)
|
Non-current liabilities
|
|
|
511
|
|
|
450
|
|
|
(12%
|
)
|
Total liabilities
|
|
|
1,990
|
|
|
1,556
|
|
|
(22%
|
)
|
Shareholders equity
|
|
|
3,871
|
|
|
3,808
|
|
|
(2%
|
)
|
|
|
|
(1) |
|
Percentage changes from September 30, 2006 to June 30,
2007. |
As of June 30, 2007, our current assets decreased
significantly as compared to September 30, 2006 primarily
due to lower trade accounts receivables, which resulted from
lower revenues and faster collections in June 2007 compared to
September 2006. Although bit production growth exceeded bit
shipments during the nine months ended June 30, 2007, the
reduction in our manufacturing cost and the write-down of
inventory based on the market price decline in the three months
ended June 30, 2007 caused a slight decrease in inventory
compared to September 30, 2006. These effects were
partially offset by investments made in marketable securities
pending use in capital expenditures and an increase of other
current assets mainly due to an increase of income tax refunds
and the fair value of derivatives. Non-current assets increased
slightly because increases from the combined effect of capital
expenditures for our capacity expansion and equity in earnings
of Inotera exceeded depreciation recorded during the nine months
ended June 30, 2007.
As of June 30, 2007, current liabilities decreased
substantially compared to September 30, 2006 primarily as a
result of the full repayment of 344 million on our
short-term loan due to Infineon and reduced current tax
liabilities as a result of lower taxable income during the nine
months ended June 30, 2007. In addition, trade
accounts payable declined mainly due to reduced transfer prices
from our foundries as result of the sharp decline of average
selling prices in the DRAM market especially in the three months
ended June 30, 2007 compared to the three months ended
September 30, 2006. As of June 30, 2007, non-current
liabilities decreased compared to September 30, 2006 mainly
due to the reclassification of portions of long-term debt and
other non-current liabilities approaching their current maturity
to current liabilities.
As of June 30, 2007, our shareholders equity
decreased to 3,808 million, mainly due to foreign
currency translation losses affecting equity of
90 million during the nine months ended June 30,
2007, which were only partially offset by our net income of
16 million.
7
Liquidity
Cash
Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in
millions)
|
|
Net cash provided by operating
activities
|
|
|
66
|
|
|
|
45
|
|
|
|
61
|
|
|
|
769
|
|
Net cash used in investing
activities
|
|
|
(257
|
)
|
|
|
(238
|
)
|
|
|
(725
|
)
|
|
|
(724
|
)
|
Net cash provided by (used in)
financing activities
|
|
|
(14
|
)
|
|
|
(48
|
)
|
|
|
466
|
|
|
|
(343
|
)
|
Effect of foreign exchange rate
changes on
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
cash and cash equivalents
|
|
|
5
|
|
|
|
(2
|
)
|
|
|
4
|
|
|
|
(5
|
)
|
Cash and cash equivalents at end
of period
|
|
|
438
|
|
|
|
629
|
|
|
|
438
|
|
|
|
629
|
|
Our operating cash flow improved substantially from an inflow of
61 million in the nine months ended June 30,
2006 to an inflow of 769 million in the nine months
ended June 30, 2007. This was caused in part by our return
to profitability after the nine months ended June 30, 2006.
We earned net income of 16 million in the nine months
ended June 30, 2007. However, our net loss in the three
months ended June 30, 2007 negatively impacted our
operating cash flow compared to the three months ended
March 31, 2007. Depreciation and amortization decreased by
28 million mainly as a result of lower capital
expenditures in former periods and certain equipment reaching
the end of its depreciable life prior to the beginning of the
2007 financial year. Our operating cash flow during the three
and nine months ended June 30, 2007 benefited substantially
from the faster collection of trade accounts receivable.
Cash used in investing activities reflect the capital
expenditures we made as we continued to invest in Property,
Plant & Equipment during all periods. Our cash used in
investing activities was stable in the nine months ended
June 30, 2007 as purchases of marketable securities offset
a temporary decrease in our investment in property, plant and
equipment.
Cash used in financing activities during the nine months ended
June 30, 2007 refers principally to the repayment of
344 million of short-term debt to Infineon. During
the nine months ended June 30, 2006, financing was
principally provided by investments by and advances from
Infineon.
Free
Cash Flow
Free cash flow is a non-GAAP financial measure which is
determined as follows from our combined and consolidated
statements of cash flows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in
millions)
|
|
Net cash provided by operating
activities
|
|
|
66
|
|
|
|
45
|
|
|
|
61
|
|
|
|
769
|
|
Net cash used in investing
activities
|
|
|
(257
|
)
|
|
|
(238
|
)
|
|
|
(725
|
)
|
|
|
(724
|
)
|
Purchases of marketable
securities, net
|
|
|
168
|
|
|
|
1
|
|
|
|
168
|
|
|
|
131
|
|
Free Cash Flow
|
|
|
(23
|
)
|
|
|
(192
|
)
|
|
|
(496
|
)
|
|
|
176
|
|
Our free cash flow in the three months ended June 30, 2007,
was negative as result of the significant decline of our net
sales due to the sharp decline of average selling prices in this
period. Nevertheless in the nine months ended June 30, 2007
our free cash flow remained positive mainly due to our
profitable operations in the first six months and capital
expenditures that were lower than cash provided from operating
activities.
Capital
Expenditures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three
months
|
|
For the nine
months
|
|
|
ended
June 30,
|
|
ended
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
(in
millions)
|
|
Purchases of property, plant and
equipment
|
|
|
89
|
|
|
236
|
|
|
571
|
|
|
601
|
8
Our capital expenditures for the nine months ended June 30,
2007, consisted primarily of equipment upgrades at our 300mm
facility in Dresden and capacity expansion at our 300mm fab in
Richmond, Virginia.
In March 2007, we announced plans to expand capacity at our
back-end manufacturing facility in Suzhou, China for which we
expect capital expenditures of 250 million over the
next three years. We also plan to invest up to
150 million over the next five years to build a new
DRAM module manufacturing facility in Johor, Malaysia. In April
2007, we also announced plans to construct a new front-end
manufacturing facility in Singapore, for which we plan to invest
approximately 2 billion over the next five years.
For the 2007 financial year, we expect capital expenditures to
be around 900 million. In a further response to the
recent market weakness we have reduced our planned capital
expenditures for the 2008 financial year to a range between
650 million to 750 million.
Outlook for the
Fourth Quarter and 2007 Financial Year
In the fourth quarter of the 2007 financial year, we expect our
bit production to grow by 15 to 20 percent, mainly based on
increased in-house and partner capacities and continued
productivity improvements from the ongoing conversion to 80nm
and 75nm technologies. We target a share of bit-shipments to
non-PC
applications around 50 percent for the fourth quarter, and
expect the trend of strong demand for PC-related products to
continue.
For the full 2007 financial year, we expect bit demand for DRAM
to be driven by the continued strong growth in graphics,
consumer and communication applications, by price demand
elasticity and the move to higher density modules in the PC
market. For the 2007 financial year, we continue to estimate an
increase in bit production of between 60 and 70 percent. We
expect our share of bit-shipments to
non-PC
applications to be more than 50 percent for the full
financial year.
9
Qimonda AG and Subsidiaries
Condensed
Combined and Consolidated Statements of Operations
(Unaudited)
For the three months ended June 30, 2006 and 2007
(in millions, except for share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
Notes
|
|
|
2006
|
|
|
2007
|
|
|
2007
|
|
|
|
|
|
|
|
|
(
millions)
|
|
|
(
millions)
|
|
|
($
millions)
|
|
|
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third parties
|
|
|
|
|
|
|
972
|
|
|
|
740
|
|
|
|
1,000
|
|
Related parties
|
|
|
13
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales
|
|
|
17
|
|
|
|
977
|
|
|
|
740
|
|
|
|
1,000
|
|
|
|
Cost of goods sold
|
|
|
|
|
|
|
(762
|
)
|
|
|
(964
|
)
|
|
|
(1,303
|
)
|
|
|
Gross profit (loss)
|
|
|
|
|
|
|
215
|
|
|
|
(224
|
)
|
|
|
(303
|
)
|
|
|
Research and development expenses
|
|
|
|
|
|
|
(110
|
)
|
|
|
(98
|
)
|
|
|
(132
|
)
|
Selling, general and
administrative expenses
|
|
|
|
|
|
|
(48
|
)
|
|
|
(48
|
)
|
|
|
(65
|
)
|
Other operating income, net
|
|
|
|
|
|
|
1
|
|
|
|
4
|
|
|
|
5
|
|
|
|
Operating income (loss)
|
|
|
|
|
|
|
58
|
|
|
|
(366
|
)
|
|
|
(495
|
)
|
|
|
Interest (expense) income, net
|
|
|
13
|
|
|
|
(6
|
)
|
|
|
1
|
|
|
|
1
|
|
Equity in earnings of associated
companies
|
|
|
|
|
|
|
11
|
|
|
|
38
|
|
|
|
51
|
|
Gain on associated company share
issuance
|
|
|
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
Other non-operating income, net
|
|
|
|
|
|
|
3
|
|
|
|
6
|
|
|
|
8
|
|
Minority interests
|
|
|
|
|
|
|
(2
|
)
|
|
|
(1
|
)
|
|
|
(1
|
)
|
|
|
Income (loss) before income taxes
|
|
|
|
|
|
|
94
|
|
|
|
(322
|
)
|
|
|
(436
|
)
|
|
|
Income tax (expense) benefit
|
|
|
3
|
|
|
|
(40
|
)
|
|
|
104
|
|
|
|
141
|
|
|
|
Net income (loss)
|
|
|
|
|
|
|
54
|
|
|
|
(218
|
)
|
|
|
(295
|
)
|
|
|
Basic and diluted earnings (loss)
per share
|
|
|
4
|
|
|
|
0.18
|
|
|
|
(0.64
|
)
|
|
|
(0.86
|
)
|
|
|
See accompanying notes to the unaudited condensed combined and
consolidated financial statements.
10
Qimonda AG and
Subsidiaries
Condensed Combined and Consolidated Statements of Operations
(Unaudited)
For the nine months ended June 30, 2006 and 2007
(in millions, except for share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
Notes
|
|
|
2006
|
|
|
2007
|
|
|
2007
|
|
|
|
|
|
|
|
|
(
millions)
|
|
|
(
millions)
|
|
|
($
millions)
|
|
|
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third parties
|
|
|
|
|
|
|
2,561
|
|
|
|
2,897
|
|
|
|
3,917
|
|
Related parties
|
|
|
13
|
|
|
|
22
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales
|
|
|
17
|
|
|
|
2,583
|
|
|
|
2,897
|
|
|
|
3,917
|
|
|
|
Cost of goods sold
|
|
|
|
|
|
|
(2,158
|
)
|
|
|
(2,572
|
)
|
|
|
(3,477
|
)
|
|
|
Gross profit
|
|
|
|
|
|
|
425
|
|
|
|
325
|
|
|
|
440
|
|
|
|
Research and development expenses
|
|
|
|
|
|
|
(325
|
)
|
|
|
(291
|
)
|
|
|
(393
|
)
|
Selling, general and
administrative expenses
|
|
|
|
|
|
|
(161
|
)
|
|
|
(140
|
)
|
|
|
(189
|
)
|
Other operating (expenses) income,
net
|
|
|
|
|
|
|
(13
|
)
|
|
|
7
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss
|
|
|
|
|
|
|
(74
|
)
|
|
|
(99
|
)
|
|
|
(133
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest (expense) income, net
|
|
|
13
|
|
|
|
(22
|
)
|
|
|
4
|
|
|
|
5
|
|
Equity in earnings of associated
companies
|
|
|
|
|
|
|
38
|
|
|
|
103
|
|
|
|
139
|
|
Gain on associated company share
issuance
|
|
|
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
Other non-operating income, net
|
|
|
|
|
|
|
9
|
|
|
|
12
|
|
|
|
16
|
|
Minority interests
|
|
|
|
|
|
|
(5
|
)
|
|
|
(4
|
)
|
|
|
(5
|
)
|
|
|
Income (loss) before income taxes
|
|
|
|
|
|
|
(24
|
)
|
|
|
16
|
|
|
|
22
|
|
|
|
Income tax expense
|
|
|
3
|
|
|
|
(58
|
)
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
|
|
|
|
|
|
(82
|
)
|
|
|
16
|
|
|
|
22
|
|
|
|
Basic and diluted (loss) earnings
per share
|
|
|
4
|
|
|
|
(0.27
|
)
|
|
|
0.05
|
|
|
|
0.06
|
|
|
|
See accompanying notes to the unaudited condensed combined and
consolidated financial statements.
11
Qimonda AG and
Subsidiaries
Condensed Consolidated Balance Sheets (Unaudited)
As of September 30, 2006 and June 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
Notes
|
|
|
2006
|
|
|
2007
|
|
|
2007
|
|
|
|
|
|
|
|
|
(
millions)
|
|
|
(
millions)
|
|
|
($
millions)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
|
|
932
|
|
|
|
629
|
|
|
|
850
|
|
Marketable securities
|
|
|
|
|
|
|
138
|
|
|
|
263
|
|
|
|
356
|
|
Trade accounts receivable, net
|
|
|
5
|
|
|
|
803
|
|
|
|
364
|
|
|
|
492
|
|
Inventories
|
|
|
6
|
|
|
|
622
|
|
|
|
600
|
|
|
|
811
|
|
Deferred income taxes
|
|
|
3
|
|
|
|
47
|
|
|
|
27
|
|
|
|
37
|
|
Other current assets
|
|
|
|
|
|
|
265
|
|
|
|
302
|
|
|
|
407
|
|
|
|
Total current assets
|
|
|
|
|
|
|
2,807
|
|
|
|
2,185
|
|
|
|
2,953
|
|
|
|
Property, plant and equipment
|
|
|
|
|
|
|
2,080
|
|
|
|
2,129
|
|
|
|
2,878
|
|
Long-term investments
|
|
|
7
|
|
|
|
636
|
|
|
|
681
|
|
|
|
921
|
|
Deferred income taxes
|
|
|
3
|
|
|
|
160
|
|
|
|
200
|
|
|
|
270
|
|
Other assets
|
|
|
|
|
|
|
178
|
|
|
|
169
|
|
|
|
228
|
|
|
|
Total assets
|
|
|
|
|
|
|
5,861
|
|
|
|
5,364
|
|
|
|
7,250
|
|
|
|
Liabilities and shareholders
equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt and current
maturities
|
|
|
9, 13
|
|
|
|
344
|
|
|
|
21
|
|
|
|
28
|
|
Trade accounts payable
|
|
|
8
|
|
|
|
712
|
|
|
|
679
|
|
|
|
918
|
|
Accrued liabilities
|
|
|
|
|
|
|
160
|
|
|
|
146
|
|
|
|
197
|
|
Deferred income taxes
|
|
|
3
|
|
|
|
18
|
|
|
|
18
|
|
|
|
24
|
|
Other current liabilities
|
|
|
|
|
|
|
245
|
|
|
|
242
|
|
|
|
327
|
|
|
|
Total current liabilities
|
|
|
|
|
|
|
1,479
|
|
|
|
1,106
|
|
|
|
1,494
|
|
|
|
Long-term debt
|
|
|
9
|
|
|
|
151
|
|
|
|
128
|
|
|
|
173
|
|
Deferred income taxes
|
|
|
3
|
|
|
|
36
|
|
|
|
34
|
|
|
|
46
|
|
Other liabilities
|
|
|
|
|
|
|
324
|
|
|
|
288
|
|
|
|
389
|
|
|
|
Total liabilities
|
|
|
|
|
|
|
1,990
|
|
|
|
1,556
|
|
|
|
2,102
|
|
|
|
Shareholders equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary share capital
|
|
|
|
|
|
|
684
|
|
|
|
684
|
|
|
|
925
|
|
Additional paid-in capital
|
|
|
|
|
|
|
3,097
|
|
|
|
3,113
|
|
|
|
4,209
|
|
Retained earnings
|
|
|
|
|
|
|
224
|
|
|
|
240
|
|
|
|
324
|
|
Accumulated other comprehensive
loss
|
|
|
11
|
|
|
|
(134
|
)
|
|
|
(229
|
)
|
|
|
(310
|
)
|
|
|
Total shareholders equity
|
|
|
|
|
|
|
3,871
|
|
|
|
3,808
|
|
|
|
5,148
|
|
|
|
Total liabilities and
shareholders equity
|
|
|
|
|
|
|
5,861
|
|
|
|
5,364
|
|
|
|
7,250
|
|
|
|
See accompanying notes to the unaudited condensed combined and
consolidated financial statements.
12
Condensed Combined and Consolidated Statements of
Business/Shareholders Equity (Unaudited)
For the nine months ended June 30, 2006 and 2007
(euro in millions, except for share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments
|
|
|
Foreign
|
|
|
Additional
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued
|
|
|
Additional
|
|
|
|
|
|
by and
|
|
|
currency
|
|
|
minimum
|
|
|
Unrealized
|
|
|
|
|
|
|
|
|
|
Ordinary
shares
|
|
|
paid-in
|
|
|
Retained
|
|
|
advances from
|
|
|
translation
|
|
|
pension
|
|
|
gain/(loss)
|
|
|
|
|
|
|
Notes
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
earnings
|
|
|
Infineon
|
|
|
adjustment
|
|
|
liability
|
|
|
on
securities
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
(millions)
|
|
|
(
millions)
|
|
|
(
millions)
|
|
|
(
millions)
|
|
|
(
millions)
|
|
|
(
millions)
|
|
|
(
millions)
|
|
|
(
millions)
|
|
|
(
millions)
|
|
|
Balance as of October 1, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,034
|
|
|
|
(66
|
)
|
|
|
(1
|
)
|
|
|
|
|
|
|
2,967
|
|
|
|
Transfer of development center to
Infineon
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10
|
)
|
Net investments by and advances
from Infineon prior to May 1, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
493
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
493
|
|
Net loss prior to May 1, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(150
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(150
|
)
|
Contribution to capital and
issuance of shares on initial Formation as of May 1, 2006
|
|
|
|
|
|
|
300
|
|
|
|
600
|
|
|
|
2,772
|
|
|
|
|
|
|
|
(3,372
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6
|
|
Net income since May 1, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
68
|
|
Other comprehensive (loss) income
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(29
|
)
|
|
|
(6
|
)
|
|
|
2
|
|
|
|
(33
|
)
|
|
|
Balance as of June 30, 2006
|
|
|
|
|
|
|
300
|
|
|
|
600
|
|
|
|
2,773
|
|
|
|
68
|
|
|
|
|
|
|
|
(95
|
)
|
|
|
(7
|
)
|
|
|
2
|
|
|
|
3,341
|
|
|
|
Balance as of October 1, 2006
|
|
|
|
|
|
|
342
|
|
|
|
684
|
|
|
|
3,097
|
|
|
|
224
|
|
|
|
|
|
|
|
(132
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
3,871
|
|
|
|
Contribution by Infineon
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16
|
|
Stock-based compensation
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
Other comprehensive loss
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(90
|
)
|
|
|
|
|
|
|
(5
|
)
|
|
|
(95
|
)
|
|
|
Balance as of June 30, 2007
|
|
|
|
|
|
|
342
|
|
|
|
684
|
|
|
|
3,113
|
|
|
|
240
|
|
|
|
|
|
|
|
(222
|
)
|
|
|
(2
|
)
|
|
|
(5
|
)
|
|
|
3.808
|
|
|
|
See accompanying notes to the unaudited condensed combined and
consolidated financial statements.
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
June 30,
|
|
June 30,
|
|
|
Notes
|
|
2006
|
|
2007
|
|
2007
|
|
|
|
|
|
(
millions)
|
|
(
millions)
|
|
($
millions)
|
|
Net (loss) income
|
|
|
|
|
|
|
(82
|
)
|
|
|
16
|
|
|
|
22
|
|
Adjustments to reconcile net
(loss) income to cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
|
524
|
|
|
|
496
|
|
|
|
671
|
|
Allowance for doubtful accounts
|
|
|
5
|
|
|
|
5
|
|
|
|
(5
|
)
|
|
|
(7
|
)
|
Gain on sales of business interests
|
|
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
(3
|
)
|
Gain (Loss) on sales of long-term
assets
|
|
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
(3
|
)
|
Equity in earnings of associated
companies
|
|
|
|
|
|
|
(38
|
)
|
|
|
(103
|
)
|
|
|
(139
|
)
|
Gains on associated company share
issuance
|
|
|
|
|
|
|
(30
|
)
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
10
|
|
|
|
6
|
|
|
|
4
|
|
|
|
5
|
|
Minority interests
|
|
|
|
|
|
|
5
|
|
|
|
5
|
|
|
|
7
|
|
Deferred income taxes
|
|
|
3
|
|
|
|
23
|
|
|
|
(9
|
)
|
|
|
(12
|
)
|
Due to changes in operating assets
and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade accounts receivable
|
|
|
5
|
|
|
|
(170
|
)
|
|
|
421
|
|
|
|
569
|
|
Inventories
|
|
|
6
|
|
|
|
(196
|
)
|
|
|
12
|
|
|
|
16
|
|
Other current assets
|
|
|
|
|
|
|
(27
|
)
|
|
|
1
|
|
|
|
1
|
|
Trade accounts payable
|
|
|
8
|
|
|
|
88
|
|
|
|
(27
|
)
|
|
|
(37
|
)
|
Accrued liabilities
|
|
|
|
|
|
|
45
|
|
|
|
(10
|
)
|
|
|
(14
|
)
|
Other current liabilities
|
|
|
|
|
|
|
24
|
|
|
|
(4
|
)
|
|
|
(5
|
)
|
Other assets and liabilities
|
|
|
|
|
|
|
(116
|
)
|
|
|
(24
|
)
|
|
|
(32
|
)
|
|
|
Net cash provided by operating
activities
|
|
|
|
|
|
|
61
|
|
|
|
769
|
|
|
|
1,039
|
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of marketable securities
available for sale
|
|
|
|
|
|
|
(168
|
)
|
|
|
(147
|
)
|
|
|
(199
|
)
|
Proceeds from marketable
securities available for sale
|
|
|
|
|
|
|
|
|
|
|
16
|
|
|
|
22
|
|
Purchases of business interests
|
|
|
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
Proceeds from disposal of business
interests and dividends
|
|
|
7
|
|
|
|
|
|
|
|
27
|
|
|
|
37
|
|
Purchases of intangible assets
|
|
|
|
|
|
|
(6
|
)
|
|
|
(24
|
)
|
|
|
(32
|
)
|
Purchases of property, plant and
equipment
|
|
|
|
|
|
|
(571
|
)
|
|
|
(601
|
)
|
|
|
(813
|
)
|
Proceeds from sales of long-term
assets
|
|
|
|
|
|
|
23
|
|
|
|
5
|
|
|
|
7
|
|
|
|
Net cash used in investing
activities
|
|
|
|
|
|
|
(725
|
)
|
|
|
(724
|
)
|
|
|
(978
|
)
|
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decrease in short-term debt due
Infineon
|
|
|
9
|
|
|
|
(54
|
)
|
|
|
(344
|
)
|
|
|
(465
|
)
|
Increase (decrease) in financial
payables due related parties
|
|
|
13
|
|
|
|
(12
|
)
|
|
|
(5
|
)
|
|
|
(7
|
)
|
Decrease in financial receivables
from related parties
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of
long-term debt
|
|
|
9
|
|
|
|
44
|
|
|
|
|
|
|
|
|
|
Dividend payments to minority
shareholders
|
|
|
|
|
|
|
(5
|
)
|
|
|
(6
|
)
|
|
|
(8
|
)
|
Investments by and advances from
Infineon
|
|
|
1
|
|
|
|
493
|
|
|
|
12
|
|
|
|
16
|
|
|
|
Net cash provided by (used in)
financing activities
|
|
|
|
|
|
|
466
|
|
|
|
(343
|
)
|
|
|
(464
|
)
|
|
|
Effect of foreign exchange rate
changes on cash and cash equivalents
|
|
|
|
|
|
|
4
|
|
|
|
(5
|
)
|
|
|
(7
|
)
|
Net decrease in cash and cash
equivalents
|
|
|
|
|
|
|
(194
|
)
|
|
|
(303
|
)
|
|
|
(410
|
)
|
Cash and cash equivalents at
beginning of year
|
|
|
|
|
|
|
632
|
|
|
|
932
|
|
|
|
1,260
|
|
|
|
Cash and cash equivalents at end
of period
|
|
|
|
|
|
|
438
|
|
|
|
629
|
|
|
|
850
|
|
|
|
See accompanying notes to the unaudited condensed combined and
consolidated financial statements.
14
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
|
|
1.
|
Description of
Business, Formation and Basis of Presentation
|
Qimonda AG and its subsidiaries (collectively, the
Company or Qimonda) is one of the
worlds leading suppliers of semiconductor memory products.
It designs memory technologies and develops, manufactures,
markets and sells a large variety of memory products on a
module, component and chip level. Qimonda has operations,
investments and customers located mainly in Europe, Asia and
North America. The Company is a majority owned subsidiary of
Infineon Technologies AG (Infineon). The financial
year-end for the Company is September 30.
Effective May 1, 2006, substantially all the memory
products-related assets and liabilities, operations and
activities of Infineon (the Memory Products
business) were contributed to the Company (the
Formation). In conjunction with the Formation the
Company entered into a contribution agreement and various other
service agreements with Infineon. In cases where physical
contribution (ownership transfer) of assets and liabilities were
not feasible or cost effective, the monetary value was
transferred in the form of cash or debt.
On August 9, 2006 the Company completed its IPO on the New
York Stock Exchange through the issuance of 42 million
ordinary shares, which are traded as American Depositary Shares
(ADSs) under the symbol QI. In addition, Infineon
sold 6.3 million shares upon exercise of the
underwriters over-allotment option. As a result,
Infineons ownership interest in the Company decreased to
85.9%.
At the Formation the Companys operations in Japan and
Korea were initially held in trust for Qimondas benefit by
Infineon until the legal transfer to Qimonda takes place. The
Companys Korea operations were legally transferred to
Qimonda in October 2006. Infineon transferred the Japan
operations into a separate legal entity and contributed
additional equity of 12 during the three months ended
December 31, 2006. In the three months ended June 30,
2007 Infineon transferred the ownership of the Japan entity to
Qimonda (see note 18). The Companys investment in
Inotera Memories Inc. (Inotera), previously held in
trust by Infineon, was transferred to Qimonda in March 2007 (see
note 7). The Companys investments in Advanced Mask
Technology Center GmbH & Co. (AMTC) and
Maskhouse Building Administration GmbH & Co. KG
(BAC) are intended to be transferred by Infineon
after approval by the other shareholders in the venture,
although pursuant to the AMTC and BAC limited partnership
agreement, such consent may not be unreasonably withheld. The
accompanying financial statements include the results of
operations of these activities for all periods presented.
Basis
of Presentation
The accompanying condensed combined and consolidated financial
statements have been prepared in accordance with accounting
principles generally accepted in the United States of America
(U.S. GAAP). The accompanying financial statements are
condensed, because certain information and footnote disclosures
normally included in annual financial statements have been
condensed or omitted. In addition, the condensed consolidated
balance sheet as of September 30, 2006 was derived from
audited financial statements and condensed for comparative
purposes. In the opinion of management, the accompanying
condensed combined and consolidated financial statements contain
all adjustments necessary to present fairly the financial
position, results of operations and cash flows of the interim
periods presented. All such adjustments are of a normal
recurring nature. The results of operations for any interim
period are not necessarily indicative of results for the full
financial year. The accompanying condensed combined and
consolidated financial statements should be read in conjunction
with the audited combined and consolidated financial statements
for the year ended September 30, 2006. The accounting
policies applied in preparing the accompanying condensed
combined financial statements are consistent with those for the
year ended September 30, 2006 (see note 2).
The accompanying combined and consolidated financial statements
are presented on a combined basis for periods prior to the
Formation and on a consolidated basis for all periods thereafter.
15
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
Periods prior to the Formation are presented on a
carve-out basis and comprise the combined historical
financial statements of the transferred Memory Products business
assuming that the Company had existed as a separate legal
entity. These combined financial statements have been derived
from the consolidated financial statements and historical
accounting records of Infineon, employing the methods and
assumptions set forth below. Substantially all of the assets,
liabilities, operations and activities of the Memory Products
business are those that comprised the Memory Products segment of
Infineon during the financial periods presented prior to the
Formation.
All amounts herein are shown in millions of euro (or
) except where otherwise stated. The
accompanying balance sheet as of June 30, 2007, and the
statements of operations and cash flows for the periods then
ended are also presented in U.S. dollars ($), solely
for the convenience of the reader, at the rate of 1 =
$1.3520, the Federal Reserve noon buying rate on June 29,
2007, the last currency trading day in June 2007.
Through the Formation, the combined statements of operations
were prepared on a carve-out basis and reflect all revenues and
expenses that are attributable to the Memory Products business.
Operating expenses or revenues of the Memory Products business
specifically identified as pertaining to the Memory Products
business were charged or credited directly to it without
allocation or apportionment. This is the case for all of the
revenues appearing on the combined statements of operations.
Operating expenses that Infineon incurred were allocated to the
Memory Products business to the extent that they were related
and indirectly attributable to it.
In connection with the Formation, the Company entered into
several service agreements with Infineon. As a result, costs are
no longer allocated after the Formation, but rather charged on
the basis of these agreements (see note 13). Allocations
from Infineon during April 2006 and the seven months ended
April 30, 2006 before the Formation are reflected in the
combined statements of operations as follows:
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June 30,
2006
|
|
June 30,
2006
|
|
Cost of goods sold
|
|
|
7
|
|
|
111
|
Research and development expenses
|
|
|
2
|
|
|
17
|
Selling, general and
administrative expenses
|
|
|
9
|
|
|
75
|
|
|
|
|
|
|
|
|
|
|
18
|
|
|
203
|
|
|
|
|
|
|
|
For periods prior to the Formation, the income tax expense
reflected in the accompanying combined and consolidated
financial statements has been calculated as if the Company had
filed separate tax returns for each of the years presented. The
Companys future effective tax rate after the Formation may
differ from those indicated in the accompanying condensed
combined and consolidated financial statements prior to the
Formation.
|
|
|
Investments by
and Advances from Infineon
|
Because a direct ownership relationship did not exist among the
various entities comprising the Memory Products business prior
to the Formation, Infineons investments in and advances to
the Memory Products business represent Infineons interest
in the recorded net assets of the Memory Products business, and
are shown as business equity in lieu of shareholders
equity in the combined financial statements. Prior to the
Formation, net income (loss) of the Memory Products business
forms part of business equity (investments by and advances from
Infineon). Subsequent to the Formation net income (loss) is
attributed to retained earnings since the Company exists as a
separate legal entity. The effects of equity transactions prior
to the Formation are included in Investments by and
advances from Infineon in the accompanying combined and
consolidated financial statements. At the Formation, net
investments by and advances from Infineon were contributed to
the company as equity, which is reflected as share capital and
as additional paid in capital in the accompanying condensed
combined and consolidated statement of
business/shareholders equity. All inter-company
transactions, including purchases of inventory, charges
16
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
and cost allocations for facilities, functions and services
performed by Infineon for the Memory Products business are
reflected in this amount.
The preparation of the accompanying condensed combined and
consolidated financial statements requires management to make
estimates and assumptions that affect the reported amounts of
assets and liabilities, as well as disclosure of contingent
amounts and liabilities, at the date of the financial statements
and the reported amounts of revenues and expenses during the
periods presented. Actual results could differ materially from
such estimates made by management. In addition, due to the
significant relationship between Infineon and the Company, the
terms of the carve-out transactions, the allocations and
estimations of assets and liabilities and of expenses and other
transactions between the Memory Products business and Infineon
may not be the same as those that would have resulted from
transactions among unrelated third parties. Management believes
that the assumptions underlying the condensed combined and
consolidated financial statements are reasonable. However, these
transactions, allocations and estimates may not be indicative of
actual results that would have been obtained if the Company had
operated on a stand-alone basis, nor are they indicative of
future transactions or of the expenses or results of operations
of the Company. In addition, the process of preparing the
condensed combined and consolidated financial statements does
not permit the revaluation of historical transactions to attempt
to introduce an arms-length relationship where one did not
exist at the time. Management believes that it is not
practicable to estimate what the actual costs of the Company
would have been on a stand-alone basis if it had operated as an
unaffiliated entity. Rather than allocating the expenses that
Infineon actually incurred on behalf of the Memory Products
business, management would have had to choose from a wide range
of estimates and assumptions that could have been made regarding
joint overhead, joint financing, shared processes and other
matters. Any of these assumptions may have led to unreliable
results and would not have been more useful as an indicator of
historical business development and performance than the methods
employed in preparing the condensed combined and consolidated
financial statements.
|
|
2.
|
Recent Accounting
Pronouncements
|
In May 2005, the Financial Accounting Standards Board
(FASB) issued Statement of Financial Accounting
Standards (SFAS) No. 154, Accounting
Changes and Error Corrections. SFAS No. 154
replaces the Accounting Principles Board (APB)
Opinion No. 20, Accounting Changes, and
SFAS No. 3, Reporting Accounting Changes in
Interim Financial Statements, and changes the requirements
for the accounting and reporting of a change in accounting
principle. The Company adopted SFAS No. 154 on
October 1, 2006. The adoption of SFAS No. 154 did
not have a significant impact on the Companys consolidated
financial position or results of operations.
In July 2006, the FASB issued FASB Interpretation 48,
Accounting for Income Tax Uncertainties which
defines the threshold for recognizing the benefits of tax return
positions in the financial statements as
more-likely-than-not to be sustained by the taxing
authority. The recently issued literature also provides guidance
on the de-recognition measurement and classification of income
tax uncertainties, along with any related interest and
penalties. Interpretation No. 48 also includes guidance
concerning accounting for income tax uncertainties in interim
periods and increases the level of disclosures associated with
any recorded income tax uncertainties. Interpretation
No. 48 is effective for fiscal years beginning after
December 15, 2006. The differences between the amounts
recognized in the statements of financial position prior to the
adoption of Interpretation No. 48 and the amounts reported
after adoption will be accounted for as a cumulative-effect
adjustment recorded to the beginning balance of retained
earnings. The Company is in the process of determining the
impact, if any, that the adoption of Interpretation No. 48
will have on its consolidated financial position and results of
operations.
In September 2006, the FASB released SFAS No. 157,
Fair Value Measurements, which provides
guidance for using fair value to measure assets and liabilities.
SFAS No. 157 defines fair value, establishes a
framework for measuring fair value in generally accepted
accounting principles, and expands disclosures about fair value
measurements. The standard also responds to investors
requests for more information about the extent to which
companies measure assets and liabilities at fair value, the
information used to measure fair value, and the effect that fair
value measurements have on earnings.
17
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
SFAS No. 157 will apply whenever another standard
requires (or permits) assets or liabilities to be measured at
fair value. The standard does not expand the use of fair value
to any new circumstances. SFAS No. 157 is effective
for financial statements issued for financial years beginning
after November 15, 2007, and interim periods within those
financial years. SFAS No. 157 is effective for the
Company for financial years beginning after October 1,
2008, and interim periods within those financial years. The
Company is in the process of evaluating the impact that the
adoption of SFAS No. 157 will have on its consolidated
financial position and results of operations.
In September 2006, the FASB issued SFAS No. 158
Employers Accounting for Defined Benefit Pension
and Other Postretirement Plans an amendment of FASB
Statements No. 87, 88, 106, and
132®,
which requires an employer to recognize the overfunded or
underfunded status of a defined benefit postretirement plan
(other than a multiemployer plan) as an asset or liability in
its statement of financial position and to recognize changes in
that funded status in the year in which the changes occur
through comprehensive income of a business entity or changes in
unrestricted net assets of a
not-for-profit
organization (Recognition Provision).
SFAS No. 158 also requires an employer to measure the
funded status of a plan as of the date of its year-end statement
of financial position, with limited exceptions
(Measurement Date Provision). The Company currently
measures the funded status of its plans annually on
June 30. The Recognition Provision of
SFAS No. 158 is effective for the Company as of the
end of the fiscal year ending September 30, 2007, and the
Measurement Date Provision is effective for the Company as of
the end of the fiscal year ending September 30, 2009. As of
September 30, 2006 the application of the Recognition
Provision of SFAS No. 158 would have resulted in an
increase in other long-term liabilities of 7, an increase
in non-current deferred tax assets of 3 and an increase in
accumulated other comprehensive loss of 4. The Company
does not expect the application of the Measurement Date
Provision of SFAS No. 158 annually on September 30 to
have a significant impact on its results of operations or
financial position.
In September 2006, the SEC issued Staff Accounting
Bulletin No. 108, Considering the Effects of
Prior Year Misstatements when Quantifying Misstatements in
Current Year Financial Statements.
SAB No. 108 provides interpretive guidance on how the
effects of prior-year uncorrected misstatements should be
considered when quantifying misstatements in the current year
financial statements. SAB No. 108 requires registrants
to quantify misstatements using both an income statement
(rollover) and balance sheet (iron
curtain) approach and evaluate whether either approach
results in a misstatement that, when all relevant quantitative
and qualitative factors are considered, is material. If prior
year errors that had been previously considered immaterial now
are considered material based on either approach, no restatement
is required so long as management properly applied its previous
approach and all relevant facts and circumstances were
considered. If prior years are not restated, the cumulative
effect adjustment is recorded in opening accumulated earnings
(deficit) as of the beginning of the year of adoption.
SAB No. 108 is effective for fiscal years ending on or
after November 15, 2006, with earlier adoption encouraged.
The Company does not expect that the adoption of
SAB No. 108 will have a significant impact on its
consolidated financial position or results of operations.
In February 2007, the FASB issued SFAS No. 159
The Fair Value Option for Financial Assets and
Financial Liabilities including an amendment of FASB
Statement No. 115. SFAS No. 159 permits
entities to choose to measure certain financial assets and
liabilities and other eligible items at fair value, which are
not otherwise currently required to be measured at fair value.
Under SFAS No. 159, the decision to measure items at
fair value is made at specified election dates on an irrevocable
instrument-by-instrument
basis. Entities electing the fair value option would be required
to recognize changes in fair value in earnings and to expense
upfront cost and fees associated with the item for which the
fair value option is elected. Entities electing the fair value
option are required to distinguish on the face of the statement
of financial position, the fair value of assets and liabilities
for which the fair value option has been elected and similar
assets and liabilities measured using another measurement
attribute. If elected, SFAS No. 159 is effective as of
the beginning of the first fiscal year that begins after
November 15, 2007, with earlier adoption permitted provided
that the entity also early adopts all of the requirements of
SFAS No. 157. The Company is currently evaluating
whether to elect the option provided for in this standard.
18
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
Income (loss) before income taxes and minority interests is
attributable to the following geographic locations for the three
and nine months ended June 30, 2006 and 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Germany
|
|
|
45
|
|
|
(190
|
)
|
|
|
(159
|
)
|
|
|
(86
|
)
|
Foreign
|
|
|
51
|
|
|
(131
|
)
|
|
|
140
|
|
|
|
106
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
96
|
|
|
(321
|
)
|
|
|
(19
|
)
|
|
|
20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax benefit (expense) for the three and nine months ended
June 30, 2006 and 2007 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Current taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany
|
|
|
(20
|
)
|
|
|
27
|
|
|
(19
|
)
|
|
|
(9
|
)
|
Foreign
|
|
|
(2
|
)
|
|
|
50
|
|
|
(16
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(22
|
)
|
|
|
77
|
|
|
(35
|
)
|
|
|
(9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany
|
|
|
(14
|
)
|
|
|
1
|
|
|
(15
|
)
|
|
|
( 7
|
)
|
Foreign
|
|
|
(4
|
)
|
|
|
26
|
|
|
(8
|
)
|
|
|
16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(18
|
)
|
|
|
27
|
|
|
(23
|
)
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax (expense) benefit
|
|
|
(40
|
)
|
|
|
104
|
|
|
(58
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In the three and nine months ended June 30, 2007, the
Companys effective tax rate was lower than the combined
German statutory tax rate of 39%. This resulted from income in
jurisdictions with lower than average corporate tax rates, tax
credits, and valuation allowances. In the three and nine months
ended June 30, 2006, the effective tax rate did not fully
reflect the income and loss, respectively, for the period due to
deferred tax benefits that could not be recognized, because for
certain jurisdictions losses prior to the Formation could not be
used to offset taxable income after the Formation.
In July 2007 the German legislature passed the Corporate Tax
Reform Act 2008. This bill introduces several changes to the
taxation of German business activities, including a reduction of
the combined statutory corporate and trade tax rate in Germany
from approximately 39% to 30%. If the bill is enacted into law,
most of the changes would come into effect for the
Companys 2008 financial year. Upon enactment, which could
be during the three months ending September 30, 2007, the
Company would record the reduction in value of its deferred tax
assets in Germany at that date as tax expense.
In China, as a result of enacted tax reform legislation, a new
uniform income tax regime will become effective from
January 1, 2008. The Company incorporated these changes in
its effective and deferred tax rate which did not have a
material impact for the three and nine months ended
June 30, 2007.
|
|
4.
|
Earnings (Loss)
Per Share
|
Basic earnings (loss) per share (EPS) is calculated
by dividing net income (loss) by the weighted average number of
ordinary shares outstanding during the year.
In connection with the Formation, the ordinary shares
outstanding were increased to 300 million owned by Infineon
(see note 1). Accordingly, all applicable references to the
number of ordinary shares and per share information for periods
prior to the Formation have been restated to reflect the
300 million ordinary shares outstanding. On August 9,
2006 the Company completed its IPO on the New York Stock
Exchange through the issuance of 42 million ordinary
shares, which are traded as American Depositary Shares (ADSs).
19
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
The Company did not have any potentially dilutive instruments
outstanding for the three and nine months ended June 30,
2006. On November 24, 2006 the Company granted
1.9 million stock options pursuant to the Qimonda Stock
Option Plan (see note 10). None of these options were
dilutive to EPS for the three and nine months ended
June 30, 2007. According to the provisions of FAS
123®the
Company accounts for potentially dilutive effects from this
stock-based compensation program.
The computation of basic and diluted EPS for the three and nine
months ended June 30, 2006 and 2007 is as follows (shares
in million):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) available to
ordinary shareholders
|
|
|
54
|
|
|
|
(218
|
)
|
|
|
(82
|
)
|
|
|
16
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares
outstanding basic
|
|
|
300.0
|
|
|
|
342.0
|
|
|
|
300.0
|
|
|
|
342.0
|
|
Effect of dilutive instruments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares
outstanding diluted
|
|
|
300.0
|
|
|
|
342.0
|
|
|
|
300.0
|
|
|
|
342.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share (in
euro):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted
|
|
|
0.18
|
|
|
|
(0.64
|
)
|
|
|
(0.27
|
)
|
|
|
0.05
|
|
|
|
5.
|
Trade Accounts
Receivable, net
|
Trade accounts receivable at September 30, 2006 and
June 30, 2007 consist of the following:
|
|
|
|
|
|
|
|
|
|
|
as of
|
|
as of
|
|
|
September 30,
|
|
June 30,
|
|
|
2006
|
|
2007
|
|
Third party trade
|
|
|
764
|
|
|
|
359
|
|
Infineon group trade
(note 13)
|
|
|
61
|
|
|
|
11
|
|
Trade accounts receivable, gross
|
|
|
825
|
|
|
|
370
|
|
Allowance for doubtful accounts
|
|
|
(22
|
)
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
Trade accounts receivable, net
|
|
|
803
|
|
|
|
364
|
|
|
|
|
|
|
|
|
|
|
Inventories at September 30, 2006 and June 30, 2007
consist of the following:
|
|
|
|
|
|
|
|
|
|
|
as of
|
|
as of
|
|
|
September 30,
|
|
June 30,
|
|
|
2006
|
|
2007
|
|
Raw materials and supplies
|
|
|
54
|
|
|
|
60
|
|
Work-in-process
|
|
|
432
|
|
|
|
336
|
|
Finished goods
|
|
|
136
|
|
|
|
204
|
|
|
|
|
|
|
|
|
|
|
Total inventories
|
|
|
622
|
|
|
|
600
|
|
|
|
|
|
|
|
|
|
|
In connection with the Formation, Infineon and Qimonda entered
into a trust agreement under which Infineon placed the Inotera
shares in trust for the Company until the shares could legally
be transferred. In March 2007, the Inotera shares (except for a
portion representing less than 1% of the total shares) were
transferred to Qimonda. The Inotera shares remain subject to
Taiwanese
lock-up
provisions related to the Inotera IPO through January 2008,
after which the remaining shares are to be transferred to
Qimonda.
If Infineon were to reduce its shareholding in the Company to a
minority level before the earlier of the fifth anniversary of
the Formation and the achievement of early mass production using
58nm process technology at its manufacturing site in Dresden,
the joint venture agreement with Nanya, as amended,
20
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
could require Qimonda to transfer these Inotera shares to
Infineon. The Company agreed with Infineon that, in this event,
it would retransfer the Inotera shares back to the trust. The
trust agreement provides for Infineon to again hold the Inotera
shares in trust for Qimonda until they could be retransferred
back to the Company.
Hwa-Keng, a Taiwanese company, was formed for the purpose of
facilitating the distribution of Inotera shares to
Inoteras employees. As a result of the Inotera IPO,
Hwa-Kengs business purpose has been fulfilled and
therefore it has been dissolved. The dissolution did not have a
significant financial impact on the Company.
The limited partnership agreement relating to AMTC and BAC
requires prior written consent from the other partners, AMD and
Toppan, before Infineon can assign its partnership interest. In
the case of a transfer to an affiliate, such as Qimonda, the
consent may not be unreasonably withheld, but the interest must
be transferred back to Infineon should Infineon cease to be the
majority shareholder. Infineon is currently in the process of
negotiating with AMD and Toppan with the goal of reaching an
agreement that would allow the Company to retain the interest
even if Infineon ceases to be the majority shareholder.
On November 13, 2006 the Company sold its investment in
Ramtron through a private placement. As a result of the sale,
the Company recorded a gain of 2 as part of other
non-operating income during the three months ended
December 31, 2006.
|
|
8.
|
Trade Accounts
Payable
|
Trade accounts payable at September 30, 2006 and
June 30, 2007 consist of the following:
|
|
|
|
|
|
|
|
|
|
|
as of
|
|
as of
|
|
|
September 30,
|
|
June 30,
|
|
|
2006
|
|
2007
|
|
Third party trade
|
|
|
565
|
|
|
|
549
|
|
Infineon group trade
(note 13)
|
|
|
71
|
|
|
|
54
|
|
Associated and Related
Companies trade (note 13)
|
|
|
76
|
|
|
|
76
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
712
|
|
|
|
679
|
|
|
|
|
|
|
|
|
|
|
Debt at September 30, 2006 and June 30, 2007 consists
of the following:
|
|
|
|
|
|
|
|
|
|
|
as of
|
|
as of
|
|
|
September 30,
|
|
June 30,
|
|
|
2006
|
|
2007
|
|
Short-term debt and current
maturities:
|
|
|
|
|
|
|
|
|
Loans from Infineon
|
|
|
344
|
|
|
|
|
|
Current maturities of long-term
debt, weighted average interest rate 4.36%
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
Total short-term debt and current
maturities
|
|
|
344
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
Long-term debt:
|
|
|
|
|
|
|
|
|
Unsecured term bank loan, rate
weighted average interest 4.36%, due 2013
|
|
|
124
|
|
|
|
103
|
|
Notes payable to governmental
entity, weighted average interest rate 5.15%, due 2027
|
|
|
27
|
|
|
|
25
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt
|
|
|
151
|
|
|
|
128
|
|
|
|
|
|
|
|
|
|
|
The Company fully repaid its short-term loan from Infineon of
344 during the nine months ended June 30, 2007, of
which 48 during the three months ended June 30, 2007.
The Company has a multicurrency revolving loan facility in an
aggregate principal amount of 250. As of June 30,
2007, no amounts were outstanding under this facility and the
Company was in compliance with the facilitys covenants.
The Company can also draw, for short term purposes, on the
working capital
21
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
lines it maintains in several locations in an aggregate amount
of 166. There were no amounts outstanding under these
facilities as of June 30, 2007.
|
|
10.
|
Stock-based
Compensation
|
Infineon
Stock Option Plans
In periods prior to the Formation, certain of the Companys
employees were granted Infineon stock options as Infineon
employees pursuant to Infineons stock option plans. The
aggregate number of such options outstanding were
11.7 million and 10.0 million (of which
6.5 million and 6.8 million were exercisable) as of
June 30, 2006 and June 30, 2007, respectively. If such
options are exercised, the employees are to be given Infineon
shares in exchange for payment of the exercise price to
Infineon. Accordingly, such options do not represent potential
dilutive instruments to the Company.
Fair
value disclosures of Infineon Stock Option Plans
Effective October 1, 2005, the Company adopted
SFAS No. 123 (revised 2004) under the modified
prospective application method, and accounts for stock option
grants to its employees under the Infineon stock option plans
according to the fair value method of SFAS No. 123
(revised 2004) from that date.
The fair value of each option grant is estimated on the grant
date using the Black-Scholes option-pricing model. Prior to the
adoption of SFAS No. 123 (revised 2004), the Company
relied on historical volatility measures when estimating the
fair value of stock options granted to employees. Following the
implementation of SFAS No. 123 (revised 2004),
Infineon uses a combination of implied volatilities from traded
options on Infineons stock and historical volatility when
estimating the fair value of stock options granted to employees,
as it believes that this methodology better reflects the
expected future volatility of its stock. The expected life of
options granted is estimated based on historical experience.
Beginning on the date of adoption of SFAS No. 123
(revised 2004), forfeitures are estimated based on historical
experience; prior to the date of adoption, forfeitures were
recorded as they occurred. The risk-free rate is based on
treasury note yields at the time of grant for the estimated life
of the option. Infineon has not granted stock options to Qimonda
employees after March 1, 2006.
The following weighted-average assumptions were used in the
Black-Scholes option-pricing model for options granted during
the period indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Weighted-average assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate
|
|
|
|
|
|
|
|
|
|
|
3.08%
|
|
|
|
|
Expected volatility
|
|
|
|
|
|
|
|
|
|
|
43%
|
|
|
|
|
Dividend yield
|
|
|
|
|
|
|
|
|
|
|
0%
|
|
|
|
|
Expected life in years
|
|
|
|
|
|
|
|
|
|
|
5.07
|
|
|
|
|
Weighted-average fair value per
option at grant date in euro
|
|
|
|
|
|
|
|
|
|
|
3.19
|
|
|
|
|
Qimonda
Stock Option Plan
On November 24, 2006, the Company granted
1,899,200 Qimonda stock options to employees and the
management board of the Company. In addition, the supervisory
board received 30,000 stock appreciation rights with the
same conditions as Qimonda stock options, except that they can
only be settled in cash if exercised, which results in their
classification as a liability. The option rights may be
exercised within six years after their grant, but not before the
expiration of a vesting period that will be at least three years
from the grant date. The exercise of each option is subject to
the condition that the performance of the Companys ADSs on
the New York Stock Exchange exceeds that of the Philadelphia
Semiconductor Sector (SOX) Index on at least three consecutive
days.
22
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
Fair
value disclosures of Qimonda Stock Option Plan
A summary of the status of the Qimonda Stock Option Plan (SOP)
as of June 30, 2007, and changes during the nine months
then ended is presented below (options in millions, exercise
price in U.S. dollars, fair value in euro):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
Weighted-
|
|
|
|
|
Weighted-
|
|
average
|
|
average
|
|
|
Number of
|
|
average
|
|
remaining life
|
|
grant date
|
|
|
options
|
|
exercise
price
|
|
(in
years)
|
|
fair
value
|
|
Outstanding at beginning of period
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
1.9
|
|
$
|
15.97
|
|
|
6.00
|
|
|
3.23
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited and expired
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of period
|
|
|
1.9
|
|
$
|
15.97
|
|
|
5.41
|
|
|
3.23
|
Vested during the period
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected to ultimately vest at end
of period
|
|
|
1.9
|
|
$
|
15.97
|
|
|
5.41
|
|
|
3.23
|
Exercisable at end of period
|
|
|
|
|
|
|
|
|
|
|
|
|
The fair value of each option grant is estimated on the grant
date using a specific Monte Carlo simulation based
option-pricing model. This model accounts for vesting conditions
relating to the SOX Index and its impact on fair value.
Following the implementation of SFAS No. 123(R), the
Company uses a combination of implied and historical
volatilities from traded options on the Companys peer
group when estimating the fair value of stock options granted to
employees, as it believes that this methodology better reflects
the expected future volatility of its stock. The peer group is a
group of publicly listed companies deemed to reflect
fundamentals of the Companys stock. Forfeitures are
estimated based on historical experience. The expected life and
expected vesting period of options granted are estimated based
on the simulation. The risk-free rate is based on treasury note
yields at the time of grant for the estimated life of the option.
The following assumptions were used in the Monte Carlo
simulation to determine the fair value of options granted during
the period:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
|
June
30,
|
|
June
30,
|
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
Weighted-average assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate
|
|
|
|
|
|
|
|
|
|
|
|
4.62
|
%
|
Expected volatility, underlying ADS
|
|
|
|
|
|
|
|
|
|
|
|
45
|
%
|
Expected volatility, SOX Index
|
|
|
|
|
|
|
|
|
|
|
|
29
|
%
|
Forfeiture rate, per year
|
|
|
|
|
|
|
|
|
|
|
|
3.40
|
%
|
Dividend yield
|
|
|
|
|
|
|
|
|
|
|
|
0
|
%
|
Expected life in years
|
|
|
|
|
|
|
|
|
|
|
|
4.62
|
|
Weighted-average fair value per
option at grant date in euro
|
|
|
|
|
|
|
|
|
|
|
|
3.23
|
|
23
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
Stock-Based
Compensation Expense
Stock-based compensation expenses for the Infineon and the
Qimonda SOP were allocated as follows for the three and nine
months ended June 30, 2006 and 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Compensation expense recognized:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
2
|
|
Selling, general and
administrative expenses
|
|
|
1
|
|
|
|
|
|
|
|
3
|
|
|
|
1
|
|
Research and development expense
|
|
|
|
|
|
|
1
|
|
|
|
1
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation
expense
|
|
|
1
|
|
|
|
1
|
|
|
|
6
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Infineon Stock Options:
|
|
|
1
|
|
|
|
|
|
|
|
6
|
|
|
|
3
|
|
Qimonda Stock Options:
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
1
|
|
The amount of stock-based compensation cost which was
capitalized and remained in inventories during the period ended
June 30, 2007 was immaterial. Stock-based compensation
expense does not reflect income tax benefits, since stock
options are primarily granted in tax jurisdictions where the
expense is not deductible for tax purposes. In addition,
stock-based compensation expense did not have a cash flow effect
during the nine months ended June 30, 2007, since no
exercises of stock options occurred during the period. As of
June 30, 2007, for Infineon related stock options there was
a total of 4 in unrecognized compensation expense related
to unvested stock options which is expected to be recognized
over a remaining total period of 2.75 years, and for
Qimonda related stock options there was a total of 4 in
unrecognized compensation expense related to unvested stock
options which is expected to be recognized over a remaining
total period of 2.41 years.
As noted above, options on Infineon stock do not represent
potential dilutive instruments for Qimonda AG and accordingly,
they have no impact on diluted earnings (loss) per share (see
note 4). The Qimonda stock options did not cause a dilutive
effect in the period ended June 30, 2007 (see note 4).
|
|
11.
|
Other
Comprehensive Loss
|
The changes in the components of other comprehensive (loss)
income for the three and nine months ended June 30, 2006
and 2007 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Three months
ended
|
|
|
June 30,
2006
|
|
June 30,
2007
|
|
|
|
|
Tax
|
|
|
|
|
|
Tax
|
|
|
|
|
Pretax
|
|
Effect
|
|
Net
|
|
Pretax
|
|
Effect
|
|
Net
|
|
Accumulated other comprehensive
(loss) income beginning of period
|
|
|
(75
|
)
|
|
|
1
|
|
|
|
(74
|
)
|
|
|
(208
|
)
|
|
|
2
|
|
|
|
(206
|
)
|
Other comprehensive (loss) income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustment
|
|
|
(22
|
)
|
|
|
|
|
|
|
(22
|
)
|
|
|
(21
|
)
|
|
|
|
|
|
|
(21
|
)
|
Additional minimum pension
liability
|
|
|
(7
|
)
|
|
|
1
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized income (loss) on
securities
|
|
|
2
|
|
|
|
|
|
|
|
2
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive
(loss) income end of period
|
|
|
(102
|
)
|
|
|
2
|
|
|
|
(100
|
)
|
|
|
(231
|
)
|
|
|
2
|
|
|
|
(229
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months
ended
|
|
Nine months
ended
|
|
|
June 30,
2006
|
|
June 30,
2007
|
|
|
|
|
Tax
|
|
|
|
|
|
Tax
|
|
|
|
|
Pretax
|
|
Effect
|
|
Net
|
|
Pretax
|
|
Effect
|
|
Net
|
|
Accumulated other comprehensive
(loss) income beginning of period
|
|
|
(68
|
)
|
|
|
1
|
|
|
|
(67
|
)
|
|
|
(136
|
)
|
|
|
2
|
|
|
|
(134
|
)
|
Other comprehensive (loss) income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustment
|
|
|
(29
|
)
|
|
|
|
|
|
|
(29
|
)
|
|
|
(90
|
)
|
|
|
|
|
|
|
(90
|
)
|
Additional minimum pension
liability
|
|
|
(7
|
)
|
|
|
1
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized (loss) income on
securities
|
|
|
2
|
|
|
|
|
|
|
|
2
|
|
|
|
(5
|
)
|
|
|
|
|
|
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive
(loss) income end of period
|
|
|
(102
|
)
|
|
|
2
|
|
|
|
(100
|
)
|
|
|
(231
|
)
|
|
|
2
|
|
|
|
(229
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.
|
Supplemental Cash
Flow Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Cash paid for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest to Infineon
|
|
|
7
|
|
|
|
|
|
25
|
|
|
12
|
Interest to third parties
|
|
|
1
|
|
|
1
|
|
|
3
|
|
|
4
|
Income taxes
|
|
|
6
|
|
|
16
|
|
|
27
|
|
|
63
|
Non-cash financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Distribution to Infineon
|
|
|
|
|
|
|
|
|
10
|
|
|
|
Effective October 1, 2005 Infineon transferred the
development center in France from the Memory Products business
to the Logic business of Infineon. The net book value of
10 was reflected as a non-cash reduction to business
equity as of October 1, 2005.
The Company has transactions in the normal course of business
with Infineon group companies, Siemens group companies and with
Related and Associated Companies (together, Related
Parties). The Company purchases certain of its raw
materials, especially chipsets, from and sells certain of its
products to Related Parties. Purchases and sales to Related
Parties are generally based on market prices or manufacturing
cost plus a mark-up. Contributions by Infineon in connection
with the Formation and allocations by Infineon prior to that
date are explained in note 1. On April 3, 2006,
Siemens disposed of its remaining shareholding in Infineon.
Transactions between Qimonda and Siemens subsequent to this date
are no longer reflected as Related Party transactions.
25
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
Related Party receivables at September 30, 2006 and
June 30, 2007 consist of the following:
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
As of
|
|
|
September 30,
|
|
June 30,
|
|
|
2006
|
|
2007
|
|
Current:
|
|
|
|
|
|
|
|
|
Infineon group trade
(note 5)
|
|
|
61
|
|
|
|
11
|
|
Associated and Related
Companies trade (note 5)
|
|
|
|
|
|
|
|
|
Associated and Related
Companies financial and other
|
|
|
|
|
|
|
1
|
|
Employee receivables
|
|
|
2
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
Total Related Party receivables
|
|
|
63
|
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
Related Party payables at September 30, 2006 and
June 30, 2007 consist of the following:
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
As of
|
|
|
September 30,
|
|
June 30,
|
|
|
2006
|
|
2007
|
|
Current:
|
|
|
|
|
|
|
|
|
Infineon group trade
(note 8)
|
|
|
71
|
|
|
|
54
|
|
Associated and Related
Companies trade (note 8)
|
|
|
76
|
|
|
|
76
|
|
Infineon group
financial and other
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Related Party payables
|
|
|
156
|
|
|
|
130
|
|
|
|
|
|
|
|
|
|
|
Related Party debt at September 30, 2006 and June 30,
2007 consists of the following:
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
As of
|
|
|
September 30,
|
|
June 30,
|
|
|
2006
|
|
2007
|
|
Short-term debt:
|
|
|
|
|
|
|
|
|
Loans from Infineon (note 9)
|
|
|
344
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Related Party debt
|
|
|
344
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transactions with Related Parties during the three and nine
months ended June 30, 2006 and 2007, include the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Sales to Related Parties:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Siemens group companies
|
|
|
|
|
|
|
|
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Infineon group companies
|
|
|
2
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Associated and Related Companies
|
|
|
3
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases from Related Parties:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Siemens group companies
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
Infineon group companies
|
|
|
431
|
|
|
|
78
|
|
|
|
567
|
|
|
|
239
|
|
Associated and Related Companies
|
|
|
92
|
|
|
|
118
|
|
|
|
290
|
|
|
|
404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
523
|
|
|
|
196
|
|
|
|
861
|
|
|
|
643
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income from (expense to)
Infineon group companies:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income from Infineon
group companies
|
|
|
1
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
Interest expense to Infineon group
companies
|
|
|
(7
|
)
|
|
|
|
|
|
|
(25
|
)
|
|
|
(8
|
)
|
Purchases from Infineon during the three and nine months ended
June 30, 2006 and 2007 principally relate to products
purchased from the 200mm front-end manufacturing facility
located in Dresden, Germany (the Dresden 200mm Fab)
and are based on Infineons cost plus a margin.
26
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
Also included in purchases from Infineon are purchased services
under several service agreements entered into with Infineon in
conjunction with the Formation. These include general support
services (including sales support, logistics services,
purchasing services, human resources services, facility
management services, patent support, finance, accounting and
treasury support, legal services and strategy services),
R&D services and IT services. Transactions under these
agreements subsequent to the Formation during the two months
ended June 30, 2006 and during the three and nine months
ended June 30, 2007, respectively, are reflected in the
accompanying statements of operations as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Cost of goods sold
|
|
|
9
|
|
|
|
3
|
|
|
|
9
|
|
|
|
11
|
|
Research and development expenses
|
|
|
2
|
|
|
|
7
|
|
|
|
2
|
|
|
|
22
|
|
Selling, general and
administrative expenses
|
|
|
4
|
|
|
|
4
|
|
|
|
4
|
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15
|
|
|
|
14
|
|
|
|
15
|
|
|
|
46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In connection with the Formation, the Company entered into a
global service agreement with Infineon, whereby the parties
intend to provide standard support services to one another based
on actual costs plus a margin of 3%. The Company and Infineon
have also entered into a research and development services
agreement for the provision of research and development services
between the parties based on actual cost plus a margin of 3%.
Under the master information technology cost sharing agreement,
Infineon and the Company generally agree to share costs of a
variety of information technology services provided by one or
both parties in the common interest and for the common benefit
of both parties. In general, the parties agree to share the
fixed costs of the services provided (accounting for
approximately 53% of total costs) roughly equally and to share
variable costs in a manner that reflects each partys
contribution to those costs. Under the master information
technology service agreement, Infineon and the Company agree to
provide information technology services to one another. In
general, under all of these agreements, the service recipient
pays a fee based on actual or estimated total costs incurred
plus a margin of 3% for the period from October 1, 2006 to
September 30, 2007 and thereafter as mutually agreed from
year to year.
Dresden 200mm
Fab
In April 2006, Infineon and Qimonda entered into an agreement
for the production of wafers in the Dresden 200mm Fab. Pursuant
to the agreement, Infineon has agreed to manufacture certain
specified semiconductor memory products at the Dresden 200mm
Fab, using the Companys manufacturing technologies and
masks, and to sell them to the Company at fixed prices specified
in the agreement. The Company is required under this agreement
to pay for idle costs resulting from its purchasing fewer wafers
from Infineon than agreed upon, if Infineon cannot otherwise
utilize the capacity. The Company is obliged to indemnify
Infineon against any third party claims based on or related to
any products manufactured for the Company under this agreement.
In addition, the Company is required to indemnify Infineon
against any intellectual property infringement claims related to
the products covered by the agreement. On January 26, 2007
Qimonda and Infineon extended their agreement for the production
of wafers in the Dresden 200mm Fab through September 30,
2009.
In addition, in the contribution agreement Infineon and Qimonda
agreed to share equally any potential restructuring costs
incurred in connection with the ramp down of production in the
Dresden 200mm Fab. Restructuring costs may include severance
payments and costs relating to lower levels of production in the
Dresden 200mm Fab. Although no restructuring plan has been
established or is currently anticipated, these costs could be
material and adversely affect the Companys financial
condition and results of operations.
In February 2007, the Company established a uniform Qimonda
Pension Plan for Germany (Domestic plans) with
effect from October 1, 2006. The plan qualifies as a
defined benefit plan and, accordingly,
27
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
the change from the previous defined benefit plans is treated as
a plan amendment pursuant to SFAS No. 87. The Company
believes that the impact of this pension plan amendment on
projected benefit obligations and net periodic pension costs is
immaterial. The Company is in the process of measuring the
pension obligations on its regular measurement date
June 30, 2007 and will report the related effects, if any,
in the three months ending September 30, 2007.
In foreign countries the Companys employees participate in
the pension plans of Infineon until they are transferred to the
Companys pension plans (collectively, Foreign
plans). The pension costs and liabilities included in the
accompanying combined and consolidated financial statements and
presented below include the portion of the Infineon pension
costs and liabilities that relate to the Companys
employees participating in the respective Infineon pension plans.
The components of net periodic pension cost for the three and
nine months ended June 30, 2006 and 2007 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
|
Domestic
|
|
Foreign
|
|
Domestic
|
|
Foreign
|
|
Domestic
|
|
Foreign
|
|
Domestic
|
|
Foreign
|
|
|
Plans
|
|
Plans
|
|
Plans
|
|
Plans
|
|
Plans
|
|
Plans
|
|
Plans
|
|
Plans
|
|
Service cost
|
|
|
(1
|
)
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
(4
|
)
|
|
|
(1
|
)
|
|
|
(4
|
)
|
|
|
|
|
Interest cost
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
Expected return
on plan assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic pension cost
|
|
|
(2
|
)
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
(5
|
)
|
|
|
(1
|
)
|
|
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qimonda contributed 0 and 1, respectively, to fund
its pension plans during the three and nine months ended
June 30, 2007. During the three and nine months ended
June 30, 2006, the Company did not contribute funds to its
pension plans for periods prior to the Formation.
|
|
15.
|
Financial
Instruments
|
The Company periodically enters into financial instrument
contracts, including foreign currency forward contracts and
foreign currency options. The objective of these transactions is
to reduce the impact of exchange rate fluctuations on the
Companys foreign currency denominated net future cash
flows. The Company does not enter into financial instrument
contracts for trading or speculative purposes.
Prior to the Formation, the financial instruments of the Company
refer to those financial instruments that were specifically
identified with the Memory Products business. Derivative
contracts that Infineon entered into for group or corporate
purposes were not allocated to the Memory Products business for
purposes of the accompanying combined financial statements for
periods prior to the Formation, because there was no reasonable
allocation basis.
28
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
The euro equivalent notional amounts in millions and fair values
of the Companys outstanding foreign exchange derivative
and other financial instruments as of September 30, 2006
and June 30, 2007 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
September 30, 2006
|
|
As of
June 30, 2007
|
|
|
Notional
|
|
|
|
Notional
|
|
|
|
|
amount
|
|
Fair
value
|
|
amount
|
|
Fair
value
|
|
Forward contracts sold:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. dollar
|
|
|
168
|
|
|
(1
|
)
|
|
|
507
|
|
|
4
|
|
Japanese yen
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
|
Forward contracts purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. dollar
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
Japanese yen
|
|
|
22
|
|
|
|
|
|
|
83
|
|
|
(3
|
)
|
Singapore dollar
|
|
|
3
|
|
|
|
|
|
|
6
|
|
|
|
|
Malaysian ringgit
|
|
|
5
|
|
|
|
|
|
|
10
|
|
|
|
|
Other currencies
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
Currency options sold:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. dollar Call
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. dollar Put
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency options purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. dollar Call
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. dollar Put
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
94
|
|
|
5
|
|
|
|
107
|
|
|
16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value, net
|
|
|
|
|
|
4
|
|
|
|
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gains and losses on derivative financial instruments included in
determining net income (loss), with those related to operations
included primarily in cost of goods sold, and those related to
financial activities included in other non-operating income
(expense), for the three and nine months ended June 30,
2006 and 2007 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Net gains (losses) from foreign
currency derivatives and transactions
|
|
|
(11
|
)
|
|
|
(3
|
)
|
|
|
(5
|
)
|
|
|
(11
|
)
|
|
|
16.
|
Commitments and
Contingencies
|
Contribution
from Infineon
These contingencies described below were assigned to the Company
pursuant to the contribution agreement entered into between
Infineon and the Company in connection with the Formation.
Under the contribution agreement, the Company is required to
indemnify Infineon, in whole or in part as specified below, for
any claim (including any related expenses) arising in connection
with the liabilities, contracts, offers, uncompleted
transactions, continuing obligations, risks, encumbrances and
other liabilities Infineon incurs in connection with the matters
described below.
The contribution agreement is based on the principle that all
potential liabilities and risks in connection with legal matters
existing as of the Formation date are generally to be borne by
the business unit which caused the risk or liability or where
the risk or liability arose. Except to the limited extent
described below for the securities class action litigation and
the settled Tessera litigation (for which the Company has
different arrangements), the Company has agreed to indemnify
Infineon for all liabilities arising in connection with all
legal matters specifically described below, including court
costs and legal fees. Infineon will not settle or otherwise
agree to any of these liabilities without the Companys
prior consent. Liabilities and risks relating to the securities
class action litigation, including court costs, will be equally
shared by Infineon and the Company, but only with respect to the
amount by which the total amount payable exceeds the amount of
29
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
the corresponding accrual that Infineon transferred to the
Company at the formation. Infineon has agreed not to settle this
lawsuit without the Companys prior consent. Any expenses
incurred in connection with the assertion of claims against the
provider of directors and officers (D &
O) insurance covering Infineons two current or former
officers named as defendants in the suit will also be equally
shared. The D & O insurance provider has so far
refused coverage. The Company has agreed to indemnify Infineon
for 80% of the court costs and legal fees relating to the
recently settled litigation with Tessera.
The Company has further agreed to pay 60% of the total license
fees payable by Infineon and the Company to which Infineon and
the Company may agree in connection with two cases in which
negotiations relating to licensing and cross-licensing were
ongoing at the time of the Formation, one of which is still
ongoing.
In accordance with the general principle that all potential
risks or liabilities are to be borne by the entity which caused
the risk or liability or where the risk or liability arose, the
indemnification provisions of the contribution agreement include
the following specific allocation keys with respect to claims or
lawsuits arising after the Formation:
|
|
|
|
|
liabilities arising in connection with intellectual property
infringement claims relating to memory products were fully
allocated to the Company.
|
|
|
|
liabilities arising in connection with actual or alleged
antitrust violations with respect to DRAM products were fully
allocated to the Company.
|
Litigation
In September 2004, Infineon entered into a plea agreement with
the Antitrust Division of the U.S. Department of Justice
(DOJ) in connection with its investigation of
alleged antitrust violations in the DRAM industry. Pursuant to
this plea agreement, Infineon agreed to plead guilty to a single
count of conspiring with other unspecified DRAM manufacturers to
fix the prices of DRAM products between July 1, 1999 and
June 15, 2002, and to pay a fine of $160 million. The
fine plus accrued interest is being paid in equal annual
installments through 2009. Infineon has a continuing obligation
to cooperate with the DOJ in its ongoing investigation of other
participants in the DRAM industry. The price fixing charges
related to DRAM-product sales to six Original Equipment
Manufacturer (OEM) customers that manufacture
computers and servers. Infineon has entered into settlement
agreements with five of these OEM customers and is considering
the possibility of a settlement with the remaining OEM customer,
which purchased only a very small volume of DRAM products from
Infineon.
Subsequent to the commencement of the DOJ investigation, a
number of putative class action lawsuits were filed against
Infineon, its principal U.S. subsidiary and other DRAM suppliers.
Sixteen cases were filed between June 21, 2002 and
September 19, 2002 in the following U.S. federal district
courts: one in the Southern District of New York, five in the
District of Idaho, and ten in the Northern District of
California. Each of the federal district court cases purports to
be on behalf of a class of individuals and entities who
purchased DRAM directly from various DRAM suppliers in the
United States during a specified time period (the Direct
U.S. Purchaser Class). The complaints allege price-fixing
in violation of the Sherman Act and seek treble damages in
unspecified amounts, costs, attorneys fees, and an
injunction against the allegedly unlawful conduct.
In September 2002, the Judicial Panel on Multi-District
Litigation ordered that the foregoing federal cases be
transferred to the U.S. District Court for the Northern District
of California for coordinated or consolidated pre-trial
proceedings as part of a Multi-District Litigation
(MDL). On June 5, 2006, the Court issued an
order certifying a direct purchaser class.
In September 2005, Infineon and its principal U.S. subsidiary
entered into a definitive settlement agreement with counsel to
the Direct U.S. Purchaser Class (subject to approval by the U.S.
District Court for the Northern District of California and to an
opportunity for individual class members to opt out of the
settlement). The settlement agreement was approved by the court
on November 1, 2006 and the court entered final judgment
and dismissed the class action claims with prejudice on
November 2, 2006. Under the terms of the settlement
agreement Infineon agreed to pay approximately $21 million.
In addition to this
30
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
settlement payment, Infineon agreed to pay an additional amount
if it is proven that sales of DRAM products to the settlement
class after opt-outs during the settlement period exceeded
$208.1 million. The Company would also be responsible for
this payment. The additional amount payable would be calculated
by multiplying the amount by which these sales exceed
$208.1 million by 10.53%. The Company does not currently
expect to pay any additional amount to the class. The Company
has secured individual settlements with eight direct customers
in addition to those OEMs identified by the DOJ.
On April 28, 2006, Unisys Corporation filed a complaint
against Infineon and its principal U.S. subsidiary, among other
DRAM suppliers, alleging state and federal claims for price
fixing and seeking recovery as both a direct and indirect
purchaser of DRAM. On May 5, 2006, Honeywell International,
Inc. filed a complaint against Infineon and its principal U.S.
subsidiary, among other DRAM suppliers, alleging a claim for
price fixing under federal law, and seeking recovery as a direct
purchaser of DRAM. Both Unisys and Honeywell opted out of the
direct purchaser class and settlement, and therefore their
claims are not barred by the Companys settlement with the
Direct U.S. Purchaser Class. Both of these complaints were filed
in the Northern District of California, and have been related to
the MDL described above. On April 5, 2007 the court
dismissed the initial complaint with leave to amend for failing
to give proper notice of its claims. Unisys filed a First
Amended Complaint on May 4, 2007. Infineon, its principal
U.S. subsidiary, and the other defendants again filed a motion
to dismiss certain portions of the Unisys First Amended
Complaint on June 4, 2007. After Honeywell had filed a
stipulation of dismissal without prejudice of its lawsuit
against Infineon, the court entered the dismissal order on
April 26, 2007. Between February 28, 2007 and
March 8, 2007 four more opt-out cases were filed by All
American Semiconductor, Inc., Edge Electronics, Inc., Jaco
Electronics, Inc. and DRAM Claims Liquidation Trust, by its
Trustee, Wells Fargo Bank, N.A. The All American Semiconductor
complaint alleges claims for price-fixing under the Sherman Act.
The Edge Electronics, Jaco Electronics and DRAM Claims
Liquidation Trust complaints allege state and federal claims for
price-fixing. As with Unisys and Honeywell, the claims of these
plaintiffs are not barred by Infineons settlement with the
Direct U.S. Purchaser Class, since they opted out of the Direct
U.S. Purchaser Class and settlement before or on October 3,
2006. All four of these cases were filed in the Northern
District of California and have been related to the MDL
described above. Based upon the Courts order dismissing
portions of the initial Unisys complaint above, the plaintiffs
in all four of these opt-out cases decided to file amended
complaints on May 4, 2007. On June 4, 2007, Infineon
and its principal U.S. subsidiary answered the amended
complaints filed by All American Semiconductor, Inc., Edge
Electronics, Inc., and Jaco Electronics, Inc. Also on
June 4, 2007, Infineon and its principal U.S. subsidiary,
along with its co-defendants filed a joint motion to dismiss
certain portions of the DRAM Claims Liquidation Trust amended
complaint.
Sixty-four additional cases were filed between August 2,
2002 and October 12, 2005 in numerous federal and state
courts throughout the United States of America. Each of these
state and federal cases (except a case filed in the U.S.
District Court for the Eastern District of Pennsylvania on
May 5, 2005 on behalf of foreign purchasers) purports to be
on behalf of a class of individuals and entities who indirectly
purchased DRAM in the United States during specified time
periods commencing in or after 1999 (the Indirect U.S.
Purchaser Class). The Eastern District of Pennsylvania
case purporting to be on behalf of a class of foreign
individuals and entities who directly purchased DRAM outside of
the United States of America from July 1999 through at least
June 2002, was dismissed with prejudice and without leave to
amend on March 1, 2006. On July 31, 2006, plaintiffs
filed their opening brief on appeal, and defendants filed their
joint opening brief on September 20, 2006. No hearing date
has yet been scheduled for the appeal. The complaints variously
allege violations of the Sherman Act, Californias
Cartwright Act, various other state laws, unfair competition law
and unjust enrichment and seek treble damages in generally
unspecified amounts, restitution, costs, attorneys fees
and an injunction against the allegedly unlawful conduct.
Subsequently, twenty-three of the state (outside California) and
federal court cases and the U.S. District Court for the Eastern
District of Pennsylvania case were ordered transferred to the
U.S. District Court for the Northern District of California for
coordinated and consolidated pre-trial proceedings as part of
the MDL described above. After this transfer, the plaintiffs
dismissed two of the transferred cases. Two additional
transferred cases were subsequently remanded back to their
relevant state courts. Nineteen of the twenty-three transferred
cases are currently pending in the MDL - litigation. The
California state cases
31
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
were ordered transferred for coordinated and consolidated
pre-trial proceedings to the San Francisco County Superior
Court. The plaintiffs in the indirect purchaser cases originated
outside California which have not been transferred to the MDL
agreed to stay proceedings in those cases in favor of
proceedings on the indirect purchaser cases pending as part of
the MDL pretrial-proceedings. The defendants have filed two
motions for judgment on the pleadings directed at several of the
claims. The court entered an order on June 1, 2007 granting
in part and denying in part the defendants motions. The
order dismissed a large percentage of the indirect purchaser
plaintiffs claims, and granted leave to amend with regard
to claims under three specific state statutes. The court ruled
that the indirect purchaser plaintiffs must file a motion for
leave to amend the complaint with regard to any of the other
dismissed claims. On June 29, 2007, the indirect plaintiffs
filed both a First Amended Complaint, and a motion for leave to
file a Second Amended Complaint that attempts to resurrect some
of the claims that were dismissed. The defendants response
to the First Amended Complaint is due on July 30, 2007.
On July 13, 2006, the New York state attorney general filed
an action in the U.S. District Court for the Southern District
of New York against Infineon, its principal U.S subsidiary and
several other DRAM manufacturers on behalf of New York
governmental entities and New York consumers who purchased
products containing DRAM beginning in 1998. The plaintiffs
allege violations of state and federal antitrust laws arising
out of the same allegations of DRAM price-fixing and artificial
price inflation practices discussed above, and seek recovery of
actual and treble damages in unspecified amounts, penalties,
costs (including attorneys fees) and injunctive and other
equitable relief. On October 23, 2006, the New York case
was made part of the MDL proceedings. On July 14, 2006, the
attorneys general of California, Alaska, Arizona, Arkansas,
Colorado, Delaware, Florida, Hawaii, Idaho, Illinois, Iowa,
Louisiana, Maryland, Massachusetts, Michigan, Minnesota,
Mississippi, Nebraska, Nevada, New Mexico, North Dakota, Ohio,
Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee,
Texas, Utah, Vermont, Virginia, Washington, West Virginia and
Wisconsin filed a lawsuit in the U.S. District Court for the
Northern District of California against Infineon, its principal
U.S. subsidiary and several other DRAM manufacturers on behalf
of governmental entities, consumers and businesses in each of
those states who purchased products containing DRAM beginning in
1998. On September 8, 2006, the complaint was amended to
add claims by the attorneys general of Kentucky, Maine, New
Hampshire, North Carolina, the Northern Mariana Islands and
Rhode Island. This action is based on state and federal law
claims relating to the same alleged anticompetitive practices in
the sale of DRAM and plaintiffs seek recovery of actual and
treble damages in unspecified amounts, penalties, costs
(including attorneys fees) and injunctive and other
relief. On October 10, 2006 Infineon joined the other
defendants in filing motions to dismiss several of the claims
alleged in these two actions. A hearing on these motions to
dismiss was held on February 7, 2007. The court has not yet
ruled on these motions.
In April 2003, Infineon received a request for information from
the European Commission (the Commission) to enable
the Commission to assess the compatibility with the
Commissions rules on competition of certain practices of
which the Commission has become aware in the European market for
DRAM products. Infineon has reassessed the matter after its plea
agreement with the DOJ and made an accrual during the 2004
financial year for an amount representing the probable minimum
fine that may be imposed as a result of the Commissions
investigation. Any fine actually imposed by the Commission may
be significantly higher than the reserve established, although
Infineon cannot more accurately estimate the amount of such
actual fine. Infineon is fully cooperating with the Commission
in its investigation.
In May 2004, the Canadian Competition Bureau advised
Infineons principal U.S. subsidiary that it, its
affiliated companies and present and past directors, officers
and employees are among the targets of a formal inquiry into an
alleged conspiracy to prevent or lessen competition unduly in
the production, manufacture, sale or supply of DRAM, contrary to
the Canadian Competition Act. No formal steps (such as
subpoenas) have been taken by the Competition Bureau to date.
Infineon is cooperating with the Competition Bureau in its
inquiry.
Between December 2004 and February 2005, two putative class
proceedings were filed in the Canadian province of Quebec and
one was filed in each of Ontario and British Columbia against
Infineon, its principal U.S. subsidiary and other DRAM
manufacturers on behalf of all direct and indirect purchasers
resident in Canada who purchased DRAM or products containing
DRAM between July 1999 and June 2002, seeking damages,
investigation and administration costs, as well as interest and
legal costs.
32
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
Plaintiffs primarily allege conspiracy to unduly restrain
competition and to illegally fix the price of DRAM. In the
British Columbia action, a hearing on the certification motion
has been scheduled for August 2007. In one Quebec class action,
a tentative date for the motion for authorization
(certification) has been set for May 2008 (with some possibility
of a March 2008 date if the court calendar opens); the other
Quebec action has been stayed pending developments in the one
that is going forward.
Between September 30, 2004 and November 4, 2004, seven
securities class action complaints were filed against Infineon
and three of its current or former officers (of which one
officer was subsequently dropped as a defendant and one of which
is currently the chairman of the Companys Supervisory
Board) in the U.S. District Courts for the Northern District of
California and the Southern District of New York. The plaintiffs
voluntarily dismissed the New York cases, and on June 30,
2005 filed a consolidated amended complaint in California on
behalf of a putative class of purchasers of Infineons
publicly-traded securities, who purchased them during the period
from March 13, 2000 to July 19, 2004, effectively
combining all lawsuits. The consolidated amended complaint added
Infineons principal U.S. subsidiary and four then-current
or former employees of Infineon and its affiliate as defendants.
It alleges violations of the U.S. securities laws and asserts
that the defendants made materially false and misleading public
statements about Infineons historical and projected
financial results and competitive position because they did not
disclose Infineons alleged participation in DRAM
price-fixing activities and that, by fixing the price of DRAM,
defendants manipulated the price of Infineons securities,
thereby injuring its shareholders. The plaintiffs seek
unspecified compensatory damages, interest, costs and
attorneys fees. In September 2006, the court dismissed the
complaint with leave to amend and in October 2006 the plaintiffs
filed a second amended complaint. In March 2007, pursuant to a
stipulation agreed with the defendants, the plaintiffs withdrew
the second amended complaint and were granted a motion for leave
to file a third amended complaint. In the contribution agreement
the Company entered into with Infineon, the Company agreed to
share any future liabilities arising out of this lawsuit equally
with Infineon, including the cost of defending the suit.
On April 10, 2007, Lin Packaging Technologies, Ltd. (Lin)
filed a lawsuit against Infineon Technologies AG, Infineon
Technologies North America Corp. and an additional DRAM
manufacturer in the U.S. District Court for the Eastern District
of Texas, alleging that certain DRAM products were infringing
two Lin patents. In May 2007, Lin amended its complaint to
include Qimonda AG, Qimonda North America Corp. and Qimonda
Richmond LLC. Under the contribution agreement with Infineon,
the Company is required to indemnify Infineon for claims
(including any related expenses) arising in connection with the
aforementioned suit.
Infineon believes these claims are without merit. The Company is
currently unable to provide an estimate of the likelihood of an
unfavorable outcome to Infineon or of the amount or range of
potential loss arising from these actions. If the outcome of
these actions is unfavorable or if Infineon incurs substantial
legal fees in defending these actions regardless of outcome, it
may have a material adverse effect on the Companys
financial condition and results of operations. Infineons
directors and officers insurance carriers have
denied coverage in the securities class actions and Infineon
filed suits against the carriers in December 2005 and August
2006. Infineons claims against the D&O insurance
carriers were dismissed in November 2006 and May 2007. Infineon
filed an appeal against one of these decisions.
Liabilities related to legal proceedings are recorded when it is
probable that a liability has been incurred and the associated
amount can be reasonably estimated. Where the estimated amount
of loss is within a range of amounts and no amount within the
range is a better estimate than any other amount or the range
cannot be estimated, the minimum amount is accrued. As of
June 30, 2007, the Company had accrued liabilities in the
amount of 114 related to potential liabilities and risks
with respect to the DOJ and European antitrust investigations
and the direct and indirect purchaser litigation and settlements
described above, as well as for legal expenses relating to the
securities class actions and the Canadian antitrust
investigation and litigation described above. As additional
information becomes available, the potential liability related
to these matters will be reassessed and the estimates revised,
if necessary. These accrued liabilities would be subject to
change in the future based on new developments in each matter,
or changes in circumstances, which could have a material adverse
effect on the Companys results of operations and financial
condition.
33
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
An adverse final resolution of the investigations or lawsuits
described above could result in significant financial liability
to, and other adverse effects upon Infineon, and most likely the
Company, which would have a material adverse effect on the
Companys business, results of operations, financial
condition and cash flows. In each of these matters, the Company
is continuously evaluating the merits of its respective claims
and defending itself vigorously or seeking to arrive at
alternative resolutions in the best interests of the Company, as
its deems appropriate. Irrespective of the validity or the
successful assertion of the above referenced claims, the Company
could incur significant costs with respect to defending against
or settling such claims, which could have a material adverse
effect on its results of operations, financial position and cash
flows.
The Company is subject to various other lawsuits, legal actions,
claims and proceedings related to products, patents and other
matters incidental to its businesses. The Company has accrued a
liability for the estimated costs of adjudication of various
asserted and unasserted claims existing as of the balance sheet
date. Based upon information presently known to management, the
Company does not believe that the ultimate resolution of such
other pending matters will have a material adverse effect on the
Companys financial position, although the final resolution
of such matters could have a material adverse effect on the
Companys results of operations or cash flows at that time.
Infineon subsidiaries that were transferred to the Company as
part of the Formation have received government grants and
subsidies related to the construction and financing of certain
of its production facilities. These amounts are recognized upon
the attainment of specified criteria. Certain of these grants
have been received contingent upon the Company maintaining
compliance with certain project-related requirements for a
specified period after receipt. The Company is committed to
maintaining these requirements. Nevertheless, should such
requirements not be met, as of June 30, 2007, a maximum of
443 of these subsidies could be refundable.
The Company has guarantees outstanding to external parties of
128 as of June 30, 2007. Guarantees are mainly issued
for the payment of import duties, rentals of buildings,
contingent obligations related to government grants received and
the consolidated debt of subsidiaries. Such guarantees which
relate to Qimonda AG were transferred to the Company as part of
the Formation. The Company also agreed to indemnify Infineon
against any losses it may suffer under several guarantee and
financing arrangements that relate to its business but that
could not be transferred to it for legal, technical or practical
reasons.
On April 25, 2007, the Company and SanDisk Corporation
entered into an agreement to jointly develop and manufacture
multichip packages (MCPs) utilizing SanDisks
NAND flash and controllers and the Companys low power
mobile DRAM. The collaboration targets the need for high
capacity, integrated memory solutions for data-intensive mobile
applications. This agreement will be executed through a jointly
owned company based in Portugal, subject to the fulfillment of
certain closing conditions, in particular regulatory approval.
In June 2007 the Company entered into an agreement with
Winbond Electronics Corp., Hsinchu, Taiwan
(Winbond). Under the terms of this agreement,
Qimonda will transfer its 75nm and 58nm DRAM technology to
Winbonds 300mm facility in Taichung, Taiwan. In return,
Winbond will manufacture DRAMs for computing applications in
these technologies exclusively for Qimonda. The transfer of the
58nm-technology from Qimonda will enable Winbond also to develop
and sell respective proprietary specialty memories for which
Qimonda will receive license fees and royalties. This new
agreement is the extension of the two companies existing
cooperation which encompasses the transfer and licensing of the
Qimonda 110nm, 90nm and 80nm DRAM technologies for
Winbonds production sites.
34
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
|
|
17.
|
Operating Segment
and Geographic Information
|
The Company has one operating segment, Memory Products, which is
also its reportable segment, consistent with the manner in which
financial information is internally reported and used by the
Chief Operating Decision Maker for purposes of evaluating
business performance and allocating resources.
The following is a summary of net sales by geographic area based
on the customers billing location for the three and nine
months ended June 30, 2006 and 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended June 30,
|
|
|
Nine months ended
June 30,
|
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
|
(in millions,
except percentages)
|
|
|
(in millions,
except percentages)
|
|
|
Germany
|
|
|
74
|
|
|
|
8%
|
|
|
|
52
|
|
|
|
7%
|
|
|
|
223
|
|
|
|
9%
|
|
|
|
212
|
|
|
|
7%
|
|
Rest of Europe
|
|
|
142
|
|
|
|
14%
|
|
|
|
65
|
|
|
|
9%
|
|
|
|
331
|
|
|
|
13%
|
|
|
|
331
|
|
|
|
11%
|
|
North America
|
|
|
406
|
|
|
|
42%
|
|
|
|
244
|
|
|
|
33%
|
|
|
|
1,078
|
|
|
|
42%
|
|
|
|
1,093
|
|
|
|
38%
|
|
Asia/Pacific
|
|
|
312
|
|
|
|
32%
|
|
|
|
229
|
|
|
|
31%
|
|
|
|
837
|
|
|
|
32%
|
|
|
|
898
|
|
|
|
31%
|
|
Japan
|
|
|
43
|
|
|
|
4%
|
|
|
|
150
|
|
|
|
20%
|
|
|
|
114
|
|
|
|
4%
|
|
|
|
363
|
|
|
|
13%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
977
|
|
|
|
100%
|
|
|
|
740
|
|
|
|
100%
|
|
|
|
2,583
|
|
|
|
100%
|
|
|
|
2,897
|
|
|
|
100%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For practical purposes, the Rest of Europe region also includes
other countries and territories in the rest of the world outside
of the listed main geographic regions with aggregate sales
representing no more than 2% of total sales in any period.
During the three months ended June 30, 2007, the Company
recategorized revenues from Europe to North America consistent
with the revision of a customers billing location
according to information reviewed by the Companys chief
operating decision maker (CODM). Prior period amounts have been
reclassified to conform to the current period presentation.
The Company defines EBIT as earnings (loss) before interest and
taxes. The Companys management uses EBIT, among other
measures, to establish budgets and operational goals, to manage
the combined and consolidated Companys business and to
evaluate and report performance as part of the Infineon Group.
Because many operating decisions, such as allocations of
resources to individual projects, are made on a basis for which
the effects of financing the overall business and of taxation
are of marginal relevance, management finds a metric that
excludes the effects of interest on financing and tax expense
useful. In addition, in measuring operating performance,
particularly for the purpose of making internal decisions, such
as those relating to personnel matters, it is useful for
management to consider a measure that excludes items over which
the individuals being evaluated have minimal control, such as
enterprise-level taxation and financing. The Company reports
EBIT information because it believes that it provides investors
with meaningful information about the operating performance of
the Company in a manner similar to that which management uses to
assess and direct the business. EBIT is not a substitute for net
income, however, because the exclusion of interest and tax
expense is not appropriate when reviewing the overall
profitability of the Company.
EBIT is determined as follows from the combined and consolidated
statements of operations, without adjustment to the U.S. GAAP
amounts presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June
30,
|
|
June
30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Net (loss) income
|
|
|
54
|
|
|
|
(218
|
)
|
|
|
(82
|
)
|
|
|
16
|
|
Adjust: Interest expense (income),
net
|
|
|
6
|
|
|
|
(1
|
)
|
|
|
22
|
|
|
|
(4
|
)
|
Adjust: Income tax expense (income)
|
|
|
40
|
|
|
|
(104
|
)
|
|
|
58
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBIT
|
|
|
100
|
|
|
|
(323
|
)
|
|
|
(2
|
)
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The above EBIT results prior to the Formation differ from the
Memory Products segment results previously reported by Infineon,
primarily due to allocations of Infineon corporate expenses
(reported by Infineon as part of its Corporate and
Reconciliation segment), since they arise from corporate
directed decisions not within the direct control of segment
management, which have been reallocated to the
35
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Combined and Consolidated
Financial Statements
(euro in millions, except where otherwise stated)
Company for purposes of preparing the accompanying combined and
consolidated financial statements on a stand-alone basis.
18. Subsequent
Events
On July 10, 2007, the motion for class certification in the
Indirect U.S. Purchaser Class was filed by the plaintiffs.
On July 17, 2007, the plaintiffs of the securities class
actions filed a third amended complaint.
On July 18, 2007, in connection with the transfer of
ownership of Qimonda Japan K.K. from Infineon, the capital
increase of Qimonda AG was registered with the Commercial
Register. The new registered share capital of Qimonda AG amounts
to 684,000,002.00 and the Authorized Capital 2006/II is
reduced to 239,399,998.00.
36
SUPPLEMENTARY
INFORMATION (UNAUDITED)
Gross and Net
Cash Position
Qimonda defines gross cash position as cash and cash equivalents
and marketable securities, and net cash position as gross cash
position less short and long-term debt. Since after its
Formation, Qimonda holds a substantial portion of its available
monetary resources in the form of readily marketable securities,
which for U.S. GAAP purposes are not considered to be
cash, it reports its gross cash position to provide
investors with an understanding of its overall liquidity. The
gross and net cash positions are determined as follows from the
condensed consolidated balance sheets as of September 30,
2006 and June 30, 2007:
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
As of
|
|
|
September 30,
|
|
June 30,
|
|
|
2006
|
|
2007
|
|
Cash and cash equivalents
|
|
|
932
|
|
|
|
629
|
|
Marketable securities
|
|
|
138
|
|
|
|
263
|
|
|
|
|
|
|
|
|
|
|
Gross Cash Position
|
|
|
1,070
|
|
|
|
892
|
|
Less: Short-term debt
|
|
|
(344
|
)
|
|
|
(21
|
)
|
Long-term debt
|
|
|
(151
|
)
|
|
|
(128
|
)
|
|
|
|
|
|
|
|
|
|
Net Cash Position
|
|
|
575
|
|
|
|
743
|
|
|
|
|
|
|
|
|
|
|
Return on Capital
Employed (RoCE)
In addition to EBIT, the Qimonda management committed itself
from the 2007 financial year to put focus on measuring the
profitability of the Company compared to the capital that has
been required. Therefore the financial indicator Return on
Capital Employed (RoCE) was implemented to measure
this performance.
Earnings before interest, Capital Employed and RoCE are non-GAAP
financial measures. Reconciliations to the closest GAAP measures
net (loss) income, shareholders equity, and net (loss)
income to shareholders equity ratio, respectively, are
presented below. Capital Employed is the end period
shareholders equity less the net cash position. RoCE is
calculated as Earnings before Interest (EBI) divided by Capital
Employed. Quarterly RoCE calculations are annualized for
purposes of this ratio only, which may exceed reported annual
earnings and is not indicative of expected earnings in any
future period.
RoCE is determined as follows from the condensed consolidated
financial statements:
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
As of
|
|
|
September 30,
|
|
June 30,
|
|
|
2006
|
|
2007
|
|
Shareholders Equity
|
|
|
3,871
|
|
|
|
3,808
|
|
Less: Net Cash Position
|
|
|
(575
|
)
|
|
|
(743
|
)
|
|
|
|
|
|
|
|
|
|
Capital Employed
|
|
|
3,296
|
|
|
|
3,065
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
|
|
Nine months
|
|
|
ended
|
|
ended
|
|
|
June 30,
|
|
June 30,
|
|
|
2007
|
|
2007
|
|
Net income
|
|
|
(218
|
)
|
|
|
16
|
|
Adjust: Interest income (expense),
net
|
|
|
(1
|
)
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
Earnings (loss) before Interest
|
|
|
(219
|
)
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
Net income
(loss)/Shareholders Equity
|
|
|
(23
|
)%
|
|
|
1%
|
|
Return on Capital Employed
|
|
|
(29
|
)%
|
|
|
1%
|
|
Free Cash
Flow
Qimonda defines free cash flow as cash from operating and
investing activities excluding purchases or sales of marketable
securities. Free cash flow is not defined under U.S. GAAP and
may not be comparable with measures of the same or similar title
that are reported by other companies. Under SEC rules,
free cash flow is considered a non-GAAP financial
measure. It should not be considered as a substitute for, or
confused with, any U.S. GAAP financial measure. We believe the
most comparable U.S.
37
GAAP measure is net cash provided by operating activities. Since
we operate in a capital-intensive industry, we report free cash
flow to provide investors with a measure that can be used to
evaluate changes in liquidity after taking capital expenditures
into account. It is not intended to represent residual cash flow
available for discretionary expenditures, since debt service
requirements or other non-discretionary expenditures are not
deducted. The free cash flow is determined as follows from our
condensed combined and consolidated statements of cash flows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
June 30,
|
|
June 30,
|
|
|
2006
|
|
2007
|
|
2006
|
|
2007
|
|
Net cash provided by operating
activities
|
|
|
66
|
|
|
|
45
|
|
|
|
61
|
|
|
|
769
|
|
Net cash used in investing
activities
|
|
|
(257
|
)
|
|
|
(238
|
)
|
|
|
(725
|
)
|
|
|
(724
|
)
|
Purchases of marketable securities
available for sale
|
|
|
168
|
|
|
|
1
|
|
|
|
168
|
|
|
|
147
|
|
Proceeds from marketable
securities available for sale
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(16
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Free cash flow
|
|
|
(23
|
)
|
|
|
(192
|
)
|
|
|
(496
|
)
|
|
|
176
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employees
As of June 30, 2007, Qimonda had 12,974 employees
worldwide, including 2,345 engaged in research and development.
Market for
ordinary shares
Qimonda AG ordinary shares are traded as American Depository
Shares (ADSs) on the New York Stock Exchange under the symbol
QI.
Financial
Calendar
Qimonda plans to announce results for its financial year ending
September 30, 2007, on November 9, 2007.
Publication
date:
July 27, 2007
Contact
information
Qimonda Technologies AG
Investor Relations
Gustav-Heinemann-Ring 123
81739 Munich, Germany
Phone: +49 89 60088-1200
E-Mail:
mailto:investor.relations@qimonda.com
Visit http://www.qimonda.com/ for an electronic version of this
report and other information.
38
Risk
Factors
As a company, we face numerous risks incidental to our business.
We face risks that are inherent to companies in the
semiconductor industry, as well as operational, financial and
regulatory risks that are unique to us. Risks relating to the
semiconductor industry include the cyclical nature of the
market, which suffers from periodic downturns and industry
overcapacity. Our production related risks include the need to
match our production capacity with demand, and to avoid
interruptions in manufacturing and supplies. We may be exposed
to claims from others that we infringe their intellectual
property rights or that we are liable for damages under
warranties. We are the subject of governmental antitrust
investigations and civil claims related to those antitrust
investigations. Financial risks include our need to have access
to sufficient capital and governmental subsidies, as well as
declines in our share price which may result in impairment
charges. Our regulatory risks include potential claims for
environmental remediation. We face numerous risks due to the
international nature of our business, including volatility in
foreign countries and exchange rate fluctuations.
These and other material risks that we face are described in
detail in the Risk Factors section of our annual
report on
Form 20-F
for the year ended September 30, 2006, which we have filed
with the U.S. Securities and Exchange Commission. A copy of our
Form 20-F
is available at the Investor Relations section of our website
http://www.qimonda.com, as well as on the SECs website,
http://www.sec.gov. We encourage you to read the detailed
description of the risks that we face in our
Form 20-F.
The occurrence of one or more of the events described in the
Risk Factors section of the
Form 20-F
could have a material adverse effect on our company and our
results of operations, which could result in a drop in our share
price.
Forward-looking
Statements
This quarterly report contains forward-looking statements.
Statements that are not historical facts, including statements
about our beliefs and expectations, are forward-looking
statements.
These forward-looking statements include statements relating to
future developments of the world semiconductor market,
especially the market for memory products, Qimondas future
growth, the benefits of research and development alliances and
activities, our planned levels of future investment in the
expansion and modernization of our production capacity, the
introduction of new technology at our facilities, the
transitioning of our production processes to smaller structures,
cost savings related to such transitioning and other
initiatives, our successful development of technology based on
industry standards, our ability to offer commercially viable
products based on our technology, our ability to achieve our
cost savings and growth targets, and any further corporate
reorganization measures in that regard. These statements are
based on current plans, estimates and projections, and you
should not place too much reliance on them.
These forward-looking statements speak only as of the date they
are made, and we undertake no obligation to update any of them
in light of new information or future events. These
forward-looking statements involve inherent risks and are
subject to a number of uncertainties, including trends in demand
and prices for semiconductors generally and for our products in
particular, the success of our development efforts, both alone
and with our partners, the success of our efforts to introduce
new production processes at our facilities and the actions of
our competitors, the availability of funds for planned expansion
efforts, the outcome of antitrust investigations and litigation
matters, as well as other factors. We caution you that these and
a number of other important factors could cause actual results
or outcomes to differ materially from those expressed in any
forward-looking statement. These factors include those
identified under the heading Risk Factors in the
Form 20-F.
39
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
QIMONDA AG
|
|
Date: July 27, 2007 |
By: |
/s/ LOH KIN WAH |
|
|
|
Loh Kin Wah |
|
|
|
Chief Executive Officer and
Chairman of the Management Board |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ MICHAEL MAJERUS |
|
|
|
Dr. Michael Majerus |
|
|
|
Chief Financial Officer and
Member of the Management Board |
|
|